CN101791409A - 肽载体 - Google Patents
肽载体 Download PDFInfo
- Publication number
- CN101791409A CN101791409A CN201010003734A CN201010003734A CN101791409A CN 101791409 A CN101791409 A CN 101791409A CN 201010003734 A CN201010003734 A CN 201010003734A CN 201010003734 A CN201010003734 A CN 201010003734A CN 101791409 A CN101791409 A CN 101791409A
- Authority
- CN
- China
- Prior art keywords
- doc
- cys
- ala
- aepa
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract description 58
- 239000013598 vector Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 131
- 238000000034 method Methods 0.000 claims abstract description 96
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 24
- 201000010099 disease Diseases 0.000 claims abstract description 23
- 231100000433 cytotoxic Toxicity 0.000 claims abstract description 6
- 230000001472 cytotoxic effect Effects 0.000 claims abstract description 6
- 239000011347 resin Substances 0.000 claims description 68
- 229920005989 resin Polymers 0.000 claims description 68
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims description 44
- 150000003839 salts Chemical class 0.000 claims description 42
- 235000001014 amino acid Nutrition 0.000 claims description 25
- 229960001592 paclitaxel Drugs 0.000 claims description 25
- 241001597008 Nomeidae Species 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- 229930012538 Paclitaxel Natural products 0.000 claims description 22
- 229960004679 doxorubicin Drugs 0.000 claims description 22
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical group O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 22
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 20
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 18
- 150000001413 amino acids Chemical class 0.000 claims description 18
- 125000002769 thiazolinyl group Chemical group 0.000 claims description 16
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical group C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 claims description 14
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 229910052740 iodine Inorganic materials 0.000 claims description 12
- 108010051479 Bombesin Proteins 0.000 claims description 11
- 102000013585 Bombesin Human genes 0.000 claims description 11
- 150000001408 amides Chemical class 0.000 claims description 11
- 229910052799 carbon Inorganic materials 0.000 claims description 11
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 claims description 10
- 229960000553 somatostatin Drugs 0.000 claims description 10
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 9
- 108010056088 Somatostatin Proteins 0.000 claims description 9
- 229910052731 fluorine Inorganic materials 0.000 claims description 9
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 claims description 8
- 206010020880 Hypertrophy Diseases 0.000 claims description 8
- 102100024028 Progonadoliberin-1 Human genes 0.000 claims description 8
- 102000005157 Somatostatin Human genes 0.000 claims description 8
- 101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 claims description 8
- 229910052794 bromium Inorganic materials 0.000 claims description 8
- 229910052801 chlorine Inorganic materials 0.000 claims description 8
- 125000004122 cyclic group Chemical group 0.000 claims description 8
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims description 8
- 231100000167 toxic agent Toxicity 0.000 claims description 8
- 239000003440 toxic substance Substances 0.000 claims description 8
- 108010087791 pyroglutamylhistidine Proteins 0.000 claims description 6
- 239000003937 drug carrier Substances 0.000 claims description 5
- 201000001514 prostate carcinoma Diseases 0.000 claims description 5
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims description 4
- 206010006187 Breast cancer Diseases 0.000 claims description 4
- 208000026310 Breast neoplasm Diseases 0.000 claims description 4
- 201000009030 Carcinoma Diseases 0.000 claims description 4
- 206010009944 Colon cancer Diseases 0.000 claims description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 4
- 206010033128 Ovarian cancer Diseases 0.000 claims description 4
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 4
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 4
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims description 4
- 206010041067 Small cell lung cancer Diseases 0.000 claims description 4
- 229940045799 anthracyclines and related substance Drugs 0.000 claims description 4
- 201000008275 breast carcinoma Diseases 0.000 claims description 4
- 208000029742 colonic neoplasm Diseases 0.000 claims description 4
- 208000032839 leukemia Diseases 0.000 claims description 4
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 208000037803 restenosis Diseases 0.000 claims description 4
- 208000000587 small cell lung carcinoma Diseases 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 108010021290 LHRH Receptors Proteins 0.000 claims description 3
- 102000008238 LHRH Receptors Human genes 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 229940075620 somatostatin analogue Drugs 0.000 claims description 3
- 206010003210 Arteriosclerosis Diseases 0.000 claims description 2
- 108010073466 Bombesin Receptors Proteins 0.000 claims description 2
- 206010016654 Fibrosis Diseases 0.000 claims description 2
- 108050001286 Somatostatin Receptor Proteins 0.000 claims description 2
- 102000011096 Somatostatin receptor Human genes 0.000 claims description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000000824 cytostatic agent Substances 0.000 claims description 2
- 230000001085 cytostatic effect Effects 0.000 claims description 2
- 230000004761 fibrosis Effects 0.000 claims description 2
- 239000002434 gonadorelin derivative Substances 0.000 claims description 2
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 2
- DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 claims 2
- 239000002398 materia medica Substances 0.000 claims 1
- 230000008685 targeting Effects 0.000 abstract description 10
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 105
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 91
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 83
- 239000000243 solution Substances 0.000 description 68
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 55
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 44
- 238000004128 high performance liquid chromatography Methods 0.000 description 44
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 40
- 210000004027 cell Anatomy 0.000 description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 34
- 229940024606 amino acid Drugs 0.000 description 27
- 239000000203 mixture Substances 0.000 description 27
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 24
- 239000007787 solid Substances 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- -1 heterocyclic radical Chemical class 0.000 description 21
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 20
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 238000010168 coupling process Methods 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 238000005859 coupling reaction Methods 0.000 description 15
- 150000003053 piperidines Chemical class 0.000 description 15
- 238000001556 precipitation Methods 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 230000008878 coupling Effects 0.000 description 14
- 238000000746 purification Methods 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000001035 drying Methods 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 125000001424 substituent group Chemical group 0.000 description 12
- QXZBMSIDSOZZHK-DOPDSADYSA-N 31362-50-2 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CNC=N1 QXZBMSIDSOZZHK-DOPDSADYSA-N 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 239000012043 crude product Substances 0.000 description 11
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 11
- 239000002574 poison Substances 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- ZGYICYBLPGRURT-UHFFFAOYSA-N tri(propan-2-yl)silicon Chemical compound CC(C)[Si](C(C)C)C(C)C ZGYICYBLPGRURT-UHFFFAOYSA-N 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 239000007921 spray Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
- YYMCVZDODOMTDK-XEKBYUQMSA-N chembl3277871 Chemical compound C([C@H]1C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N1)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)[C@@H](C)O)=O)[C@H](O)C)C1=CC=CC=C1 YYMCVZDODOMTDK-XEKBYUQMSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000003480 eluent Substances 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 229910052736 halogen Inorganic materials 0.000 description 8
- 150000002367 halogens Chemical class 0.000 description 8
- 239000011630 iodine Substances 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 229960001866 silicon dioxide Drugs 0.000 description 8
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 7
- 229960000583 acetic acid Drugs 0.000 description 7
- 238000010828 elution Methods 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- 239000002287 radioligand Substances 0.000 description 7
- RINCXYDBBGOEEQ-UHFFFAOYSA-N succinic anhydride Chemical class O=C1CCC(=O)O1 RINCXYDBBGOEEQ-UHFFFAOYSA-N 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 210000000170 cell membrane Anatomy 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 230000006837 decompression Effects 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- QUTGXAIWZAMYEM-UHFFFAOYSA-N 2-cyclopentyloxyethanamine Chemical compound NCCOC1CCCC1 QUTGXAIWZAMYEM-UHFFFAOYSA-N 0.000 description 5
- XZWXFWBHYRFLEF-FSPLSTOPSA-N Ala-His Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 XZWXFWBHYRFLEF-FSPLSTOPSA-N 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 239000004471 Glycine Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 5
- 235000004279 alanine Nutrition 0.000 description 5
- 108010070944 alanylhistidine Proteins 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 239000011737 fluorine Substances 0.000 description 5
- 229960002449 glycine Drugs 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 5
- 239000002023 wood Substances 0.000 description 5
- VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- JJMDCOVWQOJGCB-UHFFFAOYSA-N 5-aminopentanoic acid Chemical compound [NH3+]CCCCC([O-])=O JJMDCOVWQOJGCB-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- VANNPISTIUFMLH-UHFFFAOYSA-N glutaric anhydride Chemical compound O=C1CCCC(=O)O1 VANNPISTIUFMLH-UHFFFAOYSA-N 0.000 description 4
- 125000001183 hydrocarbyl group Chemical group 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- SJVFAHZPLIXNDH-JOCHJYFZSA-N (2r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoic acid Chemical compound C([C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=CC=C1 SJVFAHZPLIXNDH-JOCHJYFZSA-N 0.000 description 3
- KLBPUVPNPAJWHZ-UMSFTDKQSA-N (2r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-tritylsulfanylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)SC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 KLBPUVPNPAJWHZ-UMSFTDKQSA-N 0.000 description 3
- LZOLWEQBVPVDPR-VLIAUNLRSA-N (2s,3r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]butanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H]([C@H](OC(C)(C)C)C)C(O)=O)C3=CC=CC=C3C2=C1 LZOLWEQBVPVDPR-VLIAUNLRSA-N 0.000 description 3
- SNDPXSYFESPGGJ-UHFFFAOYSA-N 2-aminopentanoic acid Chemical compound CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N Arginine Chemical compound OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Chemical compound CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 3
- 239000012964 benzotriazole Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 125000005519 fluorenylmethyloxycarbonyl group Chemical group 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 239000003701 inert diluent Substances 0.000 description 3
- 229950003188 isovaleryl diethylamide Drugs 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 229960002429 proline Drugs 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- HBGPNLPABVUVKZ-POTXQNELSA-N (1r,3as,4s,5ar,5br,7r,7ar,11ar,11br,13as,13br)-4,7-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-2,3,4,5,6,7,7a,10,11,11b,12,13,13a,13b-tetradecahydro-1h-cyclopenta[a]chrysen-9-one Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1[C@H](O)C[C@]([C@]1(C)C[C@@H]3O)(C)[C@@H]2CC[C@H]1[C@@H]1[C@]3(C)CC[C@H]1C(=C)C HBGPNLPABVUVKZ-POTXQNELSA-N 0.000 description 2
- XXMYDXUIZKNHDT-QNGWXLTQSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-(1-tritylimidazol-4-yl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C(N=C1)=CN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 XXMYDXUIZKNHDT-QNGWXLTQSA-N 0.000 description 2
- JAUKCFULLJFBFN-VWLOTQADSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-[4-[(2-methylpropan-2-yl)oxy]phenyl]propanoic acid Chemical compound C1=CC(OC(C)(C)C)=CC=C1C[C@@H](C(O)=O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 JAUKCFULLJFBFN-VWLOTQADSA-N 0.000 description 2
- CBPJQFCAFFNICX-IBGZPJMESA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC(C)C)C(O)=O)C3=CC=CC=C3C2=C1 CBPJQFCAFFNICX-IBGZPJMESA-N 0.000 description 2
- UMRUUWFGLGNQLI-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 UMRUUWFGLGNQLI-QFIPXVFZSA-N 0.000 description 2
- XQIRYUNKLVPVRR-KRWDZBQOSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)butanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC)C(O)=O)C3=CC=CC=C3C2=C1 XQIRYUNKLVPVRR-KRWDZBQOSA-N 0.000 description 2
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 2
- SWXOGPJRIDTIRL-DOUNNPEJSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s)-1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pent Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 SWXOGPJRIDTIRL-DOUNNPEJSA-N 0.000 description 2
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- PFRGGOIBYLYVKM-UHFFFAOYSA-N 15alpha-hydroxylup-20(29)-en-3-one Natural products CC(=C)C1CCC2(C)CC(O)C3(C)C(CCC4C5(C)CCC(=O)C(C)(C)C5CCC34C)C12 PFRGGOIBYLYVKM-UHFFFAOYSA-N 0.000 description 2
- NDKDFTQNXLHCGO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 NDKDFTQNXLHCGO-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine group Chemical group N[C@H](CCCCN)C(=O)O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 102100036519 Gastrin-releasing peptide Human genes 0.000 description 2
- 239000007821 HATU Substances 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 description 2
- 241000758789 Juglans Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 108010016076 Octreotide Proteins 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- SOKRNBGSNZXYIO-UHFFFAOYSA-N Resinone Natural products CC(=C)C1CCC2(C)C(O)CC3(C)C(CCC4C5(C)CCC(=O)C(C)(C)C5CCC34C)C12 SOKRNBGSNZXYIO-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- DIZZIOFQEYSTPV-UHFFFAOYSA-N [I].CO Chemical compound [I].CO DIZZIOFQEYSTPV-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- BQFCCCIRTOLPEF-UHFFFAOYSA-N chembl1976978 Chemical compound CC1=CC=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 BQFCCCIRTOLPEF-UHFFFAOYSA-N 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 239000002254 cytotoxic agent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000003818 flash chromatography Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 108010021336 lanreotide Proteins 0.000 description 2
- 229960002437 lanreotide Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 229960002700 octreotide Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000006186 oral dosage form Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 2
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 229960002730 vapreotide Drugs 0.000 description 2
- 108700029852 vapreotide Proteins 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- ZPGDWQNBZYOZTI-SFHVURJKSA-N (2s)-1-(9h-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 ZPGDWQNBZYOZTI-SFHVURJKSA-N 0.000 description 1
- SWZCTMTWRHEBIN-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=C(O)C=C1 SWZCTMTWRHEBIN-QFIPXVFZSA-N 0.000 description 1
- REITVGIIZHFVGU-IBGZPJMESA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]propanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](COC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 REITVGIIZHFVGU-IBGZPJMESA-N 0.000 description 1
- SJVFAHZPLIXNDH-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=CC=C1 SJVFAHZPLIXNDH-QFIPXVFZSA-N 0.000 description 1
- JQLPMTXRCLXOJO-NRFANRHFSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-pyridin-3-ylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=CN=C1 JQLPMTXRCLXOJO-NRFANRHFSA-N 0.000 description 1
- WDGICUODAOGOMO-DHUJRADRSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-(tritylamino)pentanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)CC(=O)NC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 WDGICUODAOGOMO-DHUJRADRSA-N 0.000 description 1
- OJBNDXHENJDCBA-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-6-(prop-2-enoxycarbonylamino)hexanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CCCCNC(=O)OCC=C)C(=O)O)C3=CC=CC=C3C2=C1 OJBNDXHENJDCBA-QFIPXVFZSA-N 0.000 description 1
- QWXZOFZKSQXPDC-NSHDSACASA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)propanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](C)C(O)=O)C3=CC=CC=C3C2=C1 QWXZOFZKSQXPDC-NSHDSACASA-N 0.000 description 1
- RXZQHZDTHUUJQJ-LURJTMIESA-N (2s)-2-amino-3-(furan-2-yl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CO1 RXZQHZDTHUUJQJ-LURJTMIESA-N 0.000 description 1
- FMUMEWVNYMUECA-LURJTMIESA-N (2s)-2-azaniumyl-5-methylhexanoate Chemical compound CC(C)CC[C@H](N)C(O)=O FMUMEWVNYMUECA-LURJTMIESA-N 0.000 description 1
- SZXBQTSZISFIAO-ZETCQYMHSA-N (2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C SZXBQTSZISFIAO-ZETCQYMHSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- HNICLNKVURBTKV-NDEPHWFRSA-N (2s)-5-[[amino-[(2,2,4,6,7-pentamethyl-3h-1-benzofuran-5-yl)sulfonylamino]methylidene]amino]-2-(9h-fluoren-9-ylmethoxycarbonylamino)pentanoic acid Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1COC(=O)N[C@H](C(O)=O)CCCN=C(N)NS(=O)(=O)C1=C(C)C(C)=C2OC(C)(C)CC2=C1C HNICLNKVURBTKV-NDEPHWFRSA-N 0.000 description 1
- UCDMMWCWPVCHLL-OSPHWJPCSA-N (2s,3r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-phenylmethoxybutanoic acid Chemical compound O([C@H](C)[C@H](NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C(O)=O)CC1=CC=CC=C1 UCDMMWCWPVCHLL-OSPHWJPCSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- XJLSEXAGTJCILF-RXMQYKEDSA-N (R)-nipecotic acid zwitterion Chemical compound OC(=O)[C@@H]1CCCNC1 XJLSEXAGTJCILF-RXMQYKEDSA-N 0.000 description 1
- BWKMGYQJPOAASG-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid Chemical compound C1=CC=C2CNC(C(=O)O)CC2=C1 BWKMGYQJPOAASG-UHFFFAOYSA-N 0.000 description 1
- FVTVMQPGKVHSEY-UHFFFAOYSA-N 1-AMINOCYCLOBUTANE CARBOXYLIC ACID Chemical compound OC(=O)C1(N)CCC1 FVTVMQPGKVHSEY-UHFFFAOYSA-N 0.000 description 1
- WOXWUZCRWJWTRT-UHFFFAOYSA-N 1-amino-1-cyclohexanecarboxylic acid Chemical compound OC(=O)C1(N)CCCCC1 WOXWUZCRWJWTRT-UHFFFAOYSA-N 0.000 description 1
- NILQLFBWTXNUOE-UHFFFAOYSA-N 1-aminocyclopentanecarboxylic acid Chemical compound OC(=O)C1(N)CCCC1 NILQLFBWTXNUOE-UHFFFAOYSA-N 0.000 description 1
- PAJPWUMXBYXFCZ-UHFFFAOYSA-N 1-aminocyclopropanecarboxylic acid Chemical compound OC(=O)C1(N)CC1 PAJPWUMXBYXFCZ-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- GUOSQNAUYHMCRU-UHFFFAOYSA-N 11-Aminoundecanoic acid Chemical compound NCCCCCCCCCCC(O)=O GUOSQNAUYHMCRU-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- YRXIMPFOTQVOHG-UHFFFAOYSA-N 2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]acetic acid Chemical compound OC(=O)CN(C)C(=O)OC(C)(C)C YRXIMPFOTQVOHG-UHFFFAOYSA-N 0.000 description 1
- JINGUCXQUOKWKH-UHFFFAOYSA-N 2-aminodecanoic acid Chemical compound CCCCCCCCC(N)C(O)=O JINGUCXQUOKWKH-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- ATAFDSCDEDHMOK-UHFFFAOYSA-N 3,3-diaminopropanoic acid Chemical compound NC(N)CC(O)=O ATAFDSCDEDHMOK-UHFFFAOYSA-N 0.000 description 1
- LINBWYYLPWJQHE-UHFFFAOYSA-N 3-(9h-fluoren-9-ylmethoxycarbonylamino)propanoic acid Chemical compound C1=CC=C2C(COC(=O)NCCC(=O)O)C3=CC=CC=C3C2=C1 LINBWYYLPWJQHE-UHFFFAOYSA-N 0.000 description 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 1
- ZZOPJRZTQNZIQM-UHFFFAOYSA-N 4-(2-aminoethyl)-2-methylpiperazine-1-carboxylic acid Chemical compound CC1CN(CCN)CCN1C(O)=O ZZOPJRZTQNZIQM-UHFFFAOYSA-N 0.000 description 1
- QGHDLJAZIIFENW-UHFFFAOYSA-N 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxy-3-prop-2-enylphenyl)propan-2-yl]-2-prop-2-enylphenol Chemical group C1=C(CC=C)C(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C(CC=C)=C1 QGHDLJAZIIFENW-UHFFFAOYSA-N 0.000 description 1
- HFXAFXVXPMUQCQ-BYPYZUCNSA-N 4-oxo-L-proline Chemical compound OC(=O)[C@@H]1CC(=O)CN1 HFXAFXVXPMUQCQ-BYPYZUCNSA-N 0.000 description 1
- UQXNEWQGGVUVQA-UHFFFAOYSA-N 8-aminooctanoic acid Chemical compound NCCCCCCCC(O)=O UQXNEWQGGVUVQA-UHFFFAOYSA-N 0.000 description 1
- VWPQCOZMXULHDM-UHFFFAOYSA-N 9-aminononanoic acid Chemical compound NCCCCCCCCC(O)=O VWPQCOZMXULHDM-UHFFFAOYSA-N 0.000 description 1
- JDDWRLPTKIOUOF-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-[[4-[2-[bis(4-methylphenyl)methylamino]-2-oxoethoxy]phenyl]-(2,4-dimethoxyphenyl)methyl]carbamate Chemical compound COC1=CC(OC)=CC=C1C(C=1C=CC(OCC(=O)NC(C=2C=CC(C)=CC=2)C=2C=CC(C)=CC=2)=CC=1)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 JDDWRLPTKIOUOF-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- SMYDMMALUBNVRU-UHFFFAOYSA-N CN(C)[P] Chemical compound CN(C)[P] SMYDMMALUBNVRU-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 108700012941 GNRH1 Proteins 0.000 description 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
- 101000632994 Homo sapiens Somatostatin Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 description 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- WBOHXLDSPBIPTP-UHFFFAOYSA-N N,N-dimethyl-1,8-naphthyridin-4-amine Chemical compound CN(C1=CC=NC2=NC=CC=C12)C WBOHXLDSPBIPTP-UHFFFAOYSA-N 0.000 description 1
- 101100386053 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cys-3 gene Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- WTOFYLAWDLQMBZ-LURJTMIESA-N beta(2-thienyl)alanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CS1 WTOFYLAWDLQMBZ-LURJTMIESA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 150000001576 beta-amino acids Chemical class 0.000 description 1
- 150000005347 biaryls Chemical group 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229940127093 camptothecin Drugs 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 229960001270 d- tartaric acid Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- KJOZJSGOIJQCGA-UHFFFAOYSA-N dichloromethane;2,2,2-trifluoroacetic acid Chemical compound ClCCl.OC(=O)C(F)(F)F KJOZJSGOIJQCGA-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
- 229960005501 duocarmycin Drugs 0.000 description 1
- 229930184221 duocarmycin Natural products 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 102000045305 human SST Human genes 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- JZWXUCFEVWHNKB-UHFFFAOYSA-N indole-1-carbaldehyde Chemical compound C1=CC=C2N(C=O)C=CC2=C1 JZWXUCFEVWHNKB-UHFFFAOYSA-N 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- SRJOCJYGOFTFLH-UHFFFAOYSA-N isonipecotic acid Chemical compound OC(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N mono-methylamine Natural products NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- CQYBNXGHMBNGCG-RNJXMRFFSA-N octahydroindole-2-carboxylic acid Chemical compound C1CCC[C@H]2N[C@H](C(=O)O)C[C@@H]21 CQYBNXGHMBNGCG-RNJXMRFFSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001525 receptor binding assay Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 150000004867 thiadiazoles Chemical class 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- DZLNHFMRPBPULJ-UHFFFAOYSA-N thioproline Chemical compound OC(=O)C1CSCN1 DZLNHFMRPBPULJ-UHFFFAOYSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- BJBUEDPLEOHJGE-IMJSIDKUSA-N trans-3-hydroxy-L-proline Chemical compound O[C@H]1CC[NH2+][C@@H]1C([O-])=O BJBUEDPLEOHJGE-IMJSIDKUSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- ORQXBVXKBGUSBA-QMMMGPOBSA-N β-cyclohexyl-alanine Chemical compound OC(=O)[C@@H](N)CC1CCCCC1 ORQXBVXKBGUSBA-QMMMGPOBSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及肽载体,描述了靶向细胞毒化合物和与治疗肿瘤和其它疾病的医疗用途相关的方法。
Description
本申请是中国专利申请200480010582.6的分案申请,原申请的申请日是2004年4月21日,发明名称是“肽载体”。
发明领域
本发明涉及治疗组合物及其在治疗疾病中的应用。尤其是,本发明提供了治疗与异常或不利的细胞增殖与迁移和/或生理作用有关的疾病的化合物、组合物以及方法。
背景技术
大多数细胞毒药物由于对需要治疗的组织或细胞缺乏选择性而呈现出不利的毒副作用。已经努力寻找各种方法以获得细胞毒药剂对靶细胞的选择性输送。
利用生物受体的配体作为药物载体将这些药物靶向输送到目标细胞中能减小毒副作用并大大改进药物输送的效率。例如,围际专利公开号WO97/19954公开了蒽环霉素(anthracycline)细胞毒药剂如多柔比星(doxorubicin)与肽激素如LHRH、铃蟾肽(bombesin)或生长抑素的偶联物。细胞毒药剂通过式-C(O)-(CH2)n-C(O)-,n=0-7的连接与肽共价结合。
与之类似,欧洲专利申请号EP1118336公开了生长抑素类似物,如奥曲肽(octreotide)、兰瑞肽(lanreotide)和伐普肽(vapreotide)与细胞毒药物,如紫杉醇(paclitaxel)、多柔比星(doxorubicin)或喜树碱(camptothecin)通过间隔基连接的结合物,该间隔基具有结构:-C(O)-(CH2)n-C(O)-,n=0-7。
美国专利申请公开号2002/0115596公开了细胞毒药剂和寡肽的结合物,其中所述寡肽的氨基酸序列是游离的前列腺特异性抗原优先断裂的序列。这样的结合物对于治疗前列腺癌和良性前列腺肥大有利用价值。
美国专利申请公开号2003/0064984公开了CC-1065和duocarmycins的细胞毒类似物与可断裂的连接体以及靶向物质,如抗体或肽的结合物。细胞毒类似物通过连接体的断裂而被释放出来。
国际专利申请号WO02/34237公开了活性物质直接共价结合到多肽上的结合物。据说该多肽能通过构象保护来稳定该活性物质,如在胃中的稳定性。
然而,仍然迫切需要靶向特异性、系统毒性和药代动力学特征得到改善的靶向细胞毒药物。
发明概述
本发明提供了靶向细胞毒化合物,其包括结合在靶向部分上的细胞毒部分,所述靶向部分为如生物受体的配体。该两部分通过连接体,如式I所示的连接体相结合:
X-B1-B2-B3-B4-Z
(I)
其中:
X是细胞毒物质或细胞抑制剂;
B1,B2,B3和B4各自独立地是(Doc)m,(Aepa)n,-(C(O)-A1-A2-A3-A4-A5-C(O))s-或(氨基酸)p,
A1和A5各自独立地是CR1R2;
R1和R2各自独立地是H,F,Br,Cl,I,C(1-30)烷基,C(2-30)烯基,取代的C(1-30)烷基,取代的C(2-30)烯基,SR3,S(O)R4或S(O)2R5,或R1和R2共同形成C(3-30)环烷基,C(3-30)杂环基或C(5-30)芳环;
R3,R4和R5各自独立地是C(1-30)烷基,C(2-30)烯基,取代的C(1-30)烷基,取代的C(2-30)烯基;
A2,A3和A4各自独立地是CR6R7,O,S,(CH2)t或缺省;
R6和R7各自独立地是H,F,Br,Cl,I,C(1-30)烷基,C(2-30)烯基,取代的C(1-30)烷基,取代的C(2-30)烯基,SR3,S(O)R4或S(O)2R5;或R6和R7共同形成环系;
m独立地是0,1,2,3,4,5,6,7,8,9或10;
n独立地是0,1,2,3,4,5,6,7,8,9或10;
p独立地是0,1或2;
s独立地是1,2,3,4或5;
t各自独立地是0,1,2或3;
Z是生物受体的配体、其类似物或所述配体或所述类似物的衍生物;条件是:
当X是多柔比星或多柔比星衍生物时,至少m和n之一不为0;且
当X是紫杉醇或紫杉醇衍生物时,B1是(氨基酸)p,其中p为1或2;
第一个优选的实施方式描述了式(I)的化合物,其中X是细胞毒部分。更优选,X是蒽环霉素。再优选,X是喜树碱、喜树碱衍生物、紫杉醇、紫杉醇衍生物、多柔比星或多柔比星衍生物;条件是:当X是多柔比星或多柔比星衍生物时,至少m和n之一不为零,而当X是紫杉醇或紫杉醇衍生物时,B1是(氨基酸)p,其中p为1或2;
所述第一个优选实施方式的进一步优选的实施方式中,所述发明描述了式(I)的化合物,其中:
X是喜树碱或喜树碱衍生物,其中所述喜树碱衍生物为:
或X是紫杉醇或紫杉醇衍生物,其中所述紫杉醇衍生物是:
或X是多柔比星或多柔比星衍生物,其中所述多柔比星衍生物是:
第二个优选的实施方式描述了式(I)的化合物,其中配体Z是生长抑素,铃蟾肽或LHRH,或它们的类似物,或所述配体或所述类似物的衍生物。
在上述第二个优选实施方式的进一步优选实施方式中,本发明描述了式(I)的化合物,其中Z是:
下式的生长抑素类似物:
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2;
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2;
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2;
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2;
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2;
-Caeg-cyclo(DCys-Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2;
-D2Nal-cyclo[Cys-Tyr-DTrp-Lys-Val-Cys]-Thr-NH2;
-DPhe-cyclo[Cys-Phe-DTrp-Lys-Thr-Cys]-Thr-ol;
-cyclo({4-(-NH-C2H4-NH-CO-O)Pro}-Phg-DTrp-Lys-Tyr(4-Bzl)-Phe);或
-DPhe-cyclo[Cys-Tyr-DTrp-Lys-Val-Cys]-Trp-NH2; 或
它们的药学可接受盐;
或下式的LHRH类似物:
Glp-His-Trp-Ser-Tyr-DLys(-)-Leu-Arg-Pro-Gly-NH2;
Glp-His-Trp-S er-Tyr-DOrn(-)-Leu-Arg-Pro-Gly-NH2;
Glp-His-Trp-Ser-Tyr-DDab(-)-Leu-Arg-Pro-Gly-NH2;
Glp-His-Trp-Ser-Tyr-DDap(-)-Leu-Arg-Pro-Gly-NH2;
Glp-His-Trp-Ser-Tyr-DApa(-)-Leu-Arg-Pro-Gly-NH2;
Glp-His-Trp-Ser-Tyr-DLys(-)-Leu-Arg-Pro-NHEt;
Glp-His-Trp-Ser-Tyr-DOrn(-)-Leu-Arg-Pro-NHEt;
Glp-His-Trp-Ser-Tyr-DDab(-)-Leu-Arg-Pro-NHEt;
Glp-His-Trp-Ser-Tyr-DDap(-)-Leu-Arg-Pro-NHEt;
Glp-His-Trp-Ser-His-DLys(-)-Trp-Tyr-Pro-Gly-NH2;
Glp-His-Trp-Ser-His-DOrn(-)-Trp-Tyr-Pro-Gly-NH2;
Glp-His-Trp-Ser-His-DDab(-)-Trp-Tyr-Pro-Gly-NH2;或
Glp-His-Trp-Ser-His-DDap(-)-Trp-Tyr-Pro-Gly-NH2;或
它们的药学可接受盐;
或下式的铃蟾肽类似物:
-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2;
-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2-NH)-Leu-NH2;
-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2-NH)-Phe-NH2;
-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2;
-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2;
-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2;
-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2;
-Gln-Trp-Ala-Val-βAla-Ala-Phe-Nle-NH2;
-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2;
-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2;
-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2;
-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2;
-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-Ala-Phe-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2-NH)-Leu-NH2;
-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2-NH)-Phe-NH2;
-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2;
-DPhe-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2;
-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2;
或它们的药学可接受盐。
第三个优选的实施方式描述了式(I)的化合物,其中,至少m和n之一不为0。
第四个优选的实施方式描述了尤其在本发明中公开结构的化合物。更优选的是本发明实施例1-79所述的化合物和中间体。在优选的是实施例19-25,28-32,40-42,45-65和74-79所述的化合物。
第五个优选实施方式是下式化合物:
或它们的药学可接受盐。更优选的是下式化合物:
或它们的药学可接受盐。甚至更优选的是包含下式的化合物:
或
或它们的药学可接受盐。
在第六个优选的实施方式中,描述了选自表A中的化合物。
在第七个优选的实施方式中,描述了选自表B中的化合物。
在第八个优选的实施方式中,描述了选自表C中的化合物。
在第九个优选的实施方式中,描述了选自表D中的化合物。
在第十个优选的实施方式中,描述了选自表E中的化合物。
在第十一个优选的实施方式中,描述了选自表F中的化合物。
在第十二个优选的实施方式中,描述了选自表G中的化合物。
在第十三个优选的实施方式中,描述了选自表H中的化合物。
在第十四个优选的实施方式中,描述了选自表I中的化合物。
本发明第二个方案提供了一种药物组合物,其包括有效量的靶向细胞毒化合物或其药学可接受盐和药学可接受载体,该靶向细胞毒化合物包括结合到靶向部分上的细胞毒部分,该靶向部分可以是例如生物受体的配体。这两部分通过连接体相结合,该连接体为如本发明的式I所定义。
本发明的第三个方案描述了为需要治疗的个体(subject)治疗疾病的方法,所述方法包括给所述个体施用治疗有效量的式I的靶向细胞毒化合物或这些化合物的药学可接受盐,其中所述疾病选自纤维化、良性前列腺增生、动脉硬化、再狭窄、乳腺癌、结肠癌、胰腺癌、前列腺癌、肺癌、小细胞肺癌、卵巢癌、表皮癌和血癌。
本发明的第四个方案描述了为需要治疗的个体治疗疾病的方法,所述方法包括给所述个体施用治疗有效量的式I的靶向细胞毒化合物或这些化合物的药学可接受盐,其中所述疾病选自良性前列腺增生、再狭窄、乳腺癌、结肠癌、胰腺癌、前列腺癌、肺癌、小细胞肺癌、卵巢癌、表皮癌和血癌。
本发明的第五个方案描述了为需要治疗的个体治疗疾病的方法,所述方法包括给所述个体施用治疗有效量的式I的靶向细胞毒化合物或这些化合物的药学可接受盐,其中所述疾病的特征是发生细胞的不良增生,所述的细胞表达一种或多种生长抑素型受体。
本发明的第六个方案描述了为需要治疗的个体治疗疾病的方法,所述方法包括给所述个体施用治疗有效量的式I的靶向细胞毒化合物或这些化合物的药学可接受盐,其中所述疾病的特征是发生细胞的不良增生,所述的细胞表达一种或多种铃蟾肽型受体。
本发明的第七个方案描述了为需要治疗的个体治疗疾病的方法,所述方法包括给所述个体施用治疗有效量的式I的靶向细胞毒化合物或这些化合物的药学可接受盐,其中所述疾病的特征是发生细胞的不良增生,所述的细胞表达一种或多种LHRH型受体。
除非另有说明,本发明中的术语“氨基酸”是指任何天然存在的氨基酸和非天然氨基酸,其包括但不限于α-氨基酸、β-氨基酸、γ-氨基酸,可能是D-氨基酸或L-氨基酸。除了N-末端氨基酸以外,所有氨基酸的缩写(如Ala)表示结构-NH-C(R)(R′)-CO-,其中,R和R′各自独立地是氢或氨基酸的侧链(如R=CH3和R′=H代表Ala),或R和R′可连接形成环系。对于N-末端氨基酸,缩写代表结构(R2R3)-N-C(R)(R′)-CO-,其中R2和R3如式(I)所定义。
优选的氨基酸的示例如下,但不限于此:Ala,Arg,Asp,Asn,Cys,Glu,pGlu,Gln,Gly,His,Ile,Leu,Lys,Met,Phe,Pro,Ser,Thr,Trp,Tyr,Val,β-Ala,Act,Apc,Gaba,Apn,Ahx,Ahp,Aoc,Anc,Adc,Aun,Ado,Acc,A3c,A4c,A5c,A6c,Aib,Orn,Dab,Dap,hArg,4Pal,3Pal,2Pal,Abu,Cha,Cit,Nle,Nva,Taz,2Thi,3Thi,Dhp,Dmt,2Fua,3Hyp,4Hyp,Inc,Inp,Ktp,hLeu.Oic,hPhe,Pip,Sar,Thz,Tic,Tle,Phg和Caeg。
本发明化合物的肽部分也可以其它方式表示,如(Tyr11)生长抑素(1-14)-NH2,其中,在第一个括号内,天然序列有氨基酸被取代(如,Tyr11取代了生长抑素中的Phe11)。第二个括号中的数字是指肽中的氨基酸数目(如,生长抑素(1-11)是指生长抑素的从第1到第11氨基酸的肽序列)。例如,(Tyr11)生长抑素(1-14)-NH2中的″NH2″表示肽的C-末端被酰胺化。(Tyr11)生长抑素(1-14)或(Tyr11)生长抑素(1-14)-OH表示C-末端是游离酸。
“烷基”是指含有一个或多个碳原子的烃基团,如果含有多个碳原子,则各碳原子是通过单键相连。烷烃基团可以是直链或包含一个或多个支链或环基团。
″取代的烷基″是指其中烃基团的一个或多个氢原子被一个或多个取代基所取代的烷基, 所述取代基选自卤素(即,氟,氯,溴和碘),-OH,-CN,-SH,-NH2,-NHCH3,-NO2,被1-6个卤素取代的-C1-2烷基,-CF3,-OCH3,-OCF3和-(CH2)0-4-COOH。不同的实施方式包含了1,2,3或4个取代基。-(CH2)0-4-COOH的存在表明是烷基酸。包含有-(CH2)0-4-COOH或由-(CH2)0-4-COOH构成的烷基酸的实例包括2-降莰烷乙酸,叔丁酸和3-环戊基丙酸。
“杂烷基”是指烃基中的一个或多个碳原子被一个或多个下述基团所取代的烷基:氨基,酰氨基,-O-或羰基。不同的实施方式包含了1或2个杂原子。
″取代的杂烷基″是指其中烃基团的一个或多个氢原子被一个或多个取代基所取代的烷基,所述取代基选自卤素(即,氟,氯,溴和碘),-OH,-CN,-SH,-NH2,-NHCH3,-NO2,被1-6个卤素取代的-C1-2烷基,-CF3,-OCH3,-OCF3和-(CH2)0-4-COOH。不同的实施方式包含了1,2,3或4个取代基。
“烯基”是指由两个或多个碳原子组成的含有一个或多个碳碳双键的烃基团。烯基可以是直链或包含一个或多个支链或环基团。
″取代的烯基″是指烯基中的一个或多个氢原子被一个或多个取代基所取代, 所述取代基选自卤素(即,氟,氯,溴和碘),-OH,-CN,-SH,-NH2,-NHCH3,-NO2,被1-6个卤素取代的-C1-2烷基,-CF3,-OCH3,-OCF3和-(CH2)0-4-COOH。不同的实施方式包含了1,2,3或4个取代基。
″芳基″是指任选取代的芳香基团,该芳香基团具有至少一个含共轭π-电子体系的环,含有至多为两个共轭或稠合的环系。芳基包括碳环芳基,杂环芳基和联芳基。优选地,芳基为5或6元环。杂环芳基中优选的原子是一个或多个硫,氧和/或氮。芳基的实例包括苯基,1-萘基,2-萘基,吲哚,喹啉,2-咪唑和9-蒽。芳基的取代基选自-C1-4烷基,-C1-4烷氧基,卤素(即,氟,氯,溴和碘),-OH,-CN,-SH,-NH2,-NO2,被1-5个卤素取代的-C1-2烷基,-CF3,-OCF3和-(CH2)0-4-COOH。不同实施方式中的芳基包含了0,1,2,3或4个取代基。
“芳烷基”是指“烷基”与“芳基”相连接。
环烷基包括碳原子数为本领域公知的单环烷基或双环烷基。
杂环包括含有一个或多个如氧,氮和/或硫的杂原子的单环和双环体系。环体系可以是芳香性的,如吡啶,吲哚,喹啉,嘧啶,噻吩,呋喃,苯并噻吩,四唑,二氢吲哚,吲唑,N-甲酸基吲哚,苯并咪唑,噻唑和噻二唑。环体系还可以是非芳香性的,如吡咯烷,哌啶,吗啉等。
普通化学技术人员能看出本发明所列出的含有杂原子取代基的某些组合所定义的化合物会在生理条件下缺乏稳定性。因此,这样的化合物不是优选化合物。
Doc是8-氨基-3,6-二氧辛酸,由下列结构表示:
Aepa是4-(2-氨基乙基)-1-羧基甲基-哌嗪,由下列结构表示:
Suc或succ是琥珀酰,有下列结构表示:
Glut或戊二酰基具有下列结构:
喜树碱部分具有以下结构:
喜树碱衍生物部分包括但不限于:
紫杉醇部分具有下列结构:
多柔比星部分具有下列结构:
多柔比星衍生物部分包括但不限于:
DLys(-)有下列结构表示:
DOrn(-)由下列结构表示:
DDab(-)由下列结构表示:
DDap(-)由下列结构表示:
DApa(-)由下列结构表示:
本发明的某些缩写定义如下:
Abu α-氨基丁酸
Acc 1-氨基-1-环(C3-C9)烷基羧酸
A3c 1-氨基-1-环丙烷羧酸
A4c 1-氨基-1-环丁烷羧酸
A5c 1-氨基-1-环戊烷羧酸
A6c 1-氨基-1-环己烷羧酸
Act 4-氨基-4-羧基四氢吡喃,由下式表示:
Aib α-氨基异丁酸
Ala或A丙氨酸
β-Ala β-丙氨酸
Apc 表示结构:
Arg或R 精氨酸
hArg 高精氨酸
Asn或N 天冬酰氨酸
Asp或D 天冬氨酸
Ava 5-氨基戊酸;
Cha β-环己基丙氨酸
Cys或C半胱氨酸
Dab 2,4-二氨基丁酸
Dap 2,3-二氨基丙酸
Dhp 3,4-二氢脯氨酸
Dmt 5,5-二甲基噻唑啉-4-羧酸
Doc 8-氨基-3,6-二氧辛酸,由下式表示:
2Fua β-(2-呋喃基)-丙氨酸
Gln或Q谷氨酰胺
Glu或E谷氨酸
PGlu或Glp焦谷氨酸
Gly或G甘氨酸
His或H组氨酸
3Hyp 反式-3-羟基-L-脯氨酸,即,(2S,3S)-3-羟基吡咯烷-2-羧酸
4Hyp 4-羟基脯氨酸,即(2S,4R)-4-羟基吡咯烷-2-羧酸
Ile或I异亮氨酸
Inc 吲哚-2-羧酸
Inp 异哌啶酸
Ktp 4-酮脯氨酸
Leu或L亮氨酸
hLeu 高亮氨酸
Lys或K赖氨酸
Met或M蛋氨酸
Nle 氨酸
Nva 戊氨酸
Oic 八氢吲哚-2-羧酸
Orn 乌氨酸
2Pal β-(2-吡啶基)丙氨酸
3Pal β-(3-吡啶基)丙氨酸
4Pal β-(4-吡啶基)丙氨酸
Phe或F苯基丙氨酸
hPhe 高苯基丙氨酸
Pip 哌啶酸
Pro或P脯氨酸
Sar 肌氨酸或N-甲基氨基乙酸
Ser或S丝氨酸
Taz β-(4-噻唑基)丙氨酸,由下式结构表示:
2Thi β-(2-噻吩基)丙氨酸
3Thi β-(3-噻吩基)丙氨酸
Thr或T苏氨酸
Thz 噻唑烷-4-羧酸
Tic 1,2,3,4-四氢异喹啉-3-羧酸
Tle 叔-亮氨酸
Trp或W色氨酸
Tyr或Y酪氨酸
Val或V缬氨酸
Gaba 4-氨基丁酸
Apn 5-氨基戊酸
Ahx 6-氨基己酸
Ahp 7-氨基庚酸
Aoc 8-氨基辛酸
Anc 9-氨基壬酸
Adc 10-氨基癸酸
Aun 11-氨基十一酸
Ado 12-氨基十二酸
Phg 苯基甘氨酸
Caeg N-(2-氨基乙基)-N-(2-胞嘧啶基-1-氧代-乙基)-甘氨酸,由下式结构表示:
本发明所用的其它缩写定义如下:
Aloc: 烯丙氧羰基
Boc: 叔丁氧羰基
Bhoc 二苯甲氧羰基
Bzl: 苄基
DCM: 二氯甲烷
Dde: 1-(4,4-二甲基-2,6-二氧环己-1-基亚基)乙基]
DIC: N,N-二异丙基碳二亚胺
DIEA: 二异丙基乙基胺
Dmab: 4-{N-(1-(4,4-二甲基-2,6-二氧环己基亚基)-3-甲基丁基)-氨基}苄基
DMAP: 4-(二甲基氨基)吡啶
DMF: 二甲基甲酰胺
DNP: 2,4-二硝基苯
Et: 乙基
Fmoc: 芴基甲氧羰基
HBTU: 2-(1H-苯并三唑-1-基)-1,1,3,3-四甲基脲鎓六氟磷酸酯
cHex 环己基
HOAT: O-(7-氮杂苯并三唑-1-基)-1,1,3,3-四甲基脲鎓六氟磷酸酯
HOBt: 1-羟基-苯并三唑
Mmt: 4-甲氧基三苯甲基
NMP: N-甲基吡咯烷酮
Pbf: 2,2,4,6,7-五甲基二氢苯并呋喃-5-磺酰基
tBu: 叔丁基
TIS: 三异丙基硅烷
TOS: 甲苯磺酰基
trt: 三苯甲基
TFA: 三氟醋酸
TFFH: 四甲基氟甲脒鎓六氟磷酸酯(tetramethylfluoroforamidiniumhexafluorophosphate)
Z: 苄氧羰基
发明详述
本发明描述了靶向细胞毒化合物以及治疗肿瘤、增生和其它与细胞不良增生有关的病症的方法。该靶向细胞毒化合物包括结合到靶向部分上的细胞毒部分,其中靶向部分为,如生物受体的配体。
利于用于本发明的生长抑素肽的实例将在此进行描述。进一步的实施例是公式或下述引用的公开专利申请中涵盖的化合物,这些申请在本发明中被全文引用:
PCT申请号WO 03/057214(2003)
美国申请号20030191134(2003)
美国申请号20030083241(2003)
美国专利号6,316,414(2001)
PCT申请号WO 02/10215(2002)
PCT申请号WO 99/22735(1999)
PCT申请号WO 98/08100(1998)
PCT申请号WO 98/44921(1998)
PCT中请号WO 98/45285(1998)
PCT申请号WO 98/44922(1998)
欧洲中请号P5 164 EU(发明人:G.Keri);
Van Binst,G.et al.Peptide Research 5:8(1992);
Horvath,A.et al.Abstract,″Conformations of Somatostatin Analogs HavingAntitumor Activity″,22nd European peptide Symposium,September 13-19,1992,Interlaken,Switzerland;
PCT申请号 WO91/09056(1991);
欧洲申请号0363589 A2(1990);
美国专利号4,904,642(1990);
美国专利号4,871,717(1989);
美国专利号4,853,371(1989);
美国专利号4,725,577(1988);
美国专利号4,684,620(1987);
美国专利号4,650,787(1987);
美国专利号4,603,120(1986);
美国专利号4,585,755(1986);
欧洲申请号0203031A2(1986);
美国专利号4,522,813(1985);
美国专利号4,486,415(1984);
美国专利号4,485,101(1984);
美国专利号4,435,385(1984);
美国专利号4,395,403(1983);
美国专利号4,369,179(1983);
美国专利号4,360,516(1982);
美国专利号4,358,439(1982);
美国专利号4,328,214(1982);
美国专利号4,316,890(1982);
美国专利号4,310,518(1982);
美国专利号4,291,022(1981);
美国专利号4,238,481(1980);
美国专利号4,235,886(1980);
美国专利号4,224,199(1980);
美国专利号4,211,693(1980);
美国专利号4,190,648(1980);
美国专利号4,146,612(1979);
美国专利号4,133,782(1979);
美国专利号5,506,339(1996);
美国专利号4,261,885(1981);
美国专利号4,728,638(1988);
美国专利号4,282,143(1981);
美国专利号4,215,039(1980);
美国专利号4,209,426(1980);
美国专利号4,190,575(1980);
欧洲专利号0389180(1990);
欧洲申请号0505680(1982);
欧洲申请号0083305(1982);
欧洲申请号0030920(1980);
PCT申请号WO88/05052(1988);
PCT申请号WO90/12811(1990);
PCT申请号WO97/01579(1997);
PCT申请号WO91/18016(1991);
英国申请号GB2,095,261(1981);和
法国申请号FR2,522,655(1983)。
利于用于本发明的LHRH(黄体生成素释放激素)肽的实例将在此进行描述。进一步的实施例是公式或下述引用的公开专利申请中涵盖的化合物,这些申请在本发明中被全文引用:
欧洲申请号0081877(1983)
欧洲申请号0328089(1989)
欧洲申请号0417454(1991)
欧洲申请号0626170(1994)
欧洲申请号0832107(1998)
欧洲申请号1340768(2003)
美国申请号2003040482(2003)
美国专利号4,317,815(1982)
美国专利号4,431,635(1984)
美国专利号4,581,169(1986)
美国专利号4,628,044(1986)
美国专利号4,642,332(1987)
美国专利号4,656,247(1987)
美国专利号4,721,775(1988)
美国专利号5,075,224(1991)
美国专利号5,140,009(1992)
美国专利号5,484,592(1996)
美国专利号5,885,966(1999)
美国专利号6,284,733(2001)
美国专利号6,559,282(2003)
PCT申请号WO 00/24764(2000)
PCT申请号WO 90/11298(1990)
PCT申请号WO 92/15330(1992)
PCT申请号WO 94/14841(1994)
PCT申请号WO 94/25060(1994)
PCT申请号WO 96/40757(1996)。
利于用于本发明的铃蟾肽的实例将在此进行描述。进一步的实施例是公式或下述引用的公开专利申请中涵盖的化合物,这些申请在本发明中被全文引用:
欧洲申请号0309297(1989)
欧洲申请号0339193(1989)
欧洲申请号0402852(1990)
欧洲申请号0434979(1991)
欧洲申请号0468497(1992)
欧洲申请号0835662(1998)
美国申请号2003050436(2003)
美国申请号2003166539(2003)
美国专利号5,084,555(1992)
美国专利号5,100,873(1992)
美国专利号5,217,955(1993)
美国专利号5,369,094(1994)
美国专利号5,410,018(1995)
美国专利号5,620,955(1997)
美国专利号5,723,578(1998)
美国专利号5,843,903(1998)
美国专利号5,877,277(1999)
美国专利号6,156,725(2000)
美国专利号6,307,017(2001)
PCT申请号WO 90/03980(1990)
PCT申请号WO 91/06563(1991)
PCT申请号WO 91/17181(1991)
PCT申请号WO 94/02018(1994)
PCT申请号WO 94/21674(1994)。
合成生长抑素、LHRH和铃蟾肽的方法是熟知记载的方法,也是本领域普通技术人员能够实施的方法。进一步合成的方法在下述实施例中进行描述。以下实施例还举例说明了本发明合成靶向细胞毒化合物的方法。
实施例1
H-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂
标题的保护的肽-树脂是利用应用生物系统公司(Applied Biosystems(ABI)(Foster City,CA))模型433A的肽合成仪,采用芴甲氧羰基(Fmoc)化学保护方法自动合成的。Rink Amide MBHA(4-甲基二苯甲基胺)树脂(Novabiochem,SanDiego,CA)具有可利用的0.72 mmol/g的取代。利用了下述的Fmoc氨基酸(AnaSpec,San Jose,CA):Fmoc-Thr(tBu)-OH,Fmoc-Cys(Trt)-OH,Fmoc-Lys(Boc)-OH,Fmoc-DTrp(Boc)-OH,Fmoc-Tyr(tBu)-OH,Fmoc-DTyr(tBu)-OH,Fmoc-Phe-OH,Fmoc-Cys(Trt)-OH,Fmoc-Thr(tBu)-OH和Fmoc-Abu-OH。以0.25 mmol规模进行合成。用含20%哌啶的N-甲基吡咯烷酮(NMP)处理30分钟去除Fmoc基团。在各偶联步骤中,首先将Fmoc氨基酸(4 eq,1mmol)在含有0.45M 2-(1-H-苯并三唑-1-基)-1,1,2,3-四甲基脲鎓六氟磷酸酯(HBTU)和0.45M1-羟基-苯并三唑(HOBT)的2mlN,N-二甲基甲酰胺(DMF)溶液中预活化。将得到的活化氨基酸酯、1mL二异丙基乙基胺(DIEA)和1mLNMP加到树脂中。设定ABI 433A肽合成仪的程序进行下列反应循环(1)用NMP清洗,(2)用含20%哌啶的NMP溶液处理30分钟,去除Fmoc保护基,(3)用NMP清洗,(4)用预先活化的Fmoc氨基酸偶联1个小时。根据序列逐个偶联到树脂上。肽链偶联完毕后,去除Fmoc,用DMF和二氯甲烷(DCM)彻底清洗树脂。
实施例2
H-Doc-Doc-Doc-Doc-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂
基本按照实施例1的方法合成标题的保护的肽-树脂。Fmoc-8-氨基-3,6-二氧辛酸(Fmoc-Doc-OH)购自Chem-Impex Intematoinal,Wood Dale,IL。H-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂(0.45 mmol的规模)合成完毕后,将保护的肽-树脂转至振荡器上的反应瓶中,进行人工分析。树脂在含有Fmoc-Doc-OH(1.5 eq,0.75 mmol)、N,N-二异丙基碳二酰亚胺(DIC,1.5 eq,0.75mmol)和HOBT(1.5 eq,0.75 mmol)的DMF溶液中振摇2个小时。用DMF清洗,然后用含20%哌啶的DMF溶液去除Fmoc保护基。用人工操作的相同方法,将其余三个Doc残基相继偶联到树脂上。用含20%哌啶的DMF溶液去除Fmoc保护基后,再用DMF和DCM清洗保护的肽-树脂。
实施例3
H-Doc-Doc-Doc-Doc-Doc-Doc-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂
基本按照实施例2所述的合成方法合成标题的保护的肽-树脂。
实施例4
H-Aepa-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂
基本按照实施例1所述的方法合成标题的保护的肽-树脂。Fmoc-4-(2-氨基乙基)-1-羧甲基-哌嗪(Fmoc-Aepa-OH)购自Neosystem,Strasbourg,France。H-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBH树脂偶联完毕后,将保护的肽-树脂转至振荡器上的反应瓶中,进行人工分析。用含有O-(7-氮杂苯并三唑-1-基)-1,1,3,3-四甲基脲鎓六氟磷酸酯(HATU,1.4 eq,0.7mmol)和1-羟基-7-氮杂苯并三唑(HOAT,1.4 eq.,0.7mmol)的2mL DMF溶液预活化Fmoc-Aepa-OH(1.5eq,0.75mmol)达2分钟。将所得活化的Fmoc-Aepa-OH的酯和1mLDIEA加至反应瓶中,振摇该混合物2个小时。用DMF清洗树脂,并用含20%哌啶的DMF溶液去除Fmoc保护基。用DMF和DCM清洗保护的肽-树脂。
实施例5
H-Doc-Doc-Doc-Doc-Aepa-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂
基本按照实施例4所述的方法合成标题的保护的肽-树脂。按照实施例2描述的相应方法偶联Fmoc-Doc-OH。
实施例6
H-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-RinkAmide MBHA树脂
基本按照实施例1所述的方法合成标题的保护的肽-树脂。Fmoc-DPhe-OH购自AnaSpec,San Jose,CA。
实施例7
H-Aepa-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-RinkAmide MBHA树脂
基本按照实施例4所述的方法合成标题的保护的肽-树脂。
实施例8
5-O-tBoc-甘氨酰-5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6’7]中氮茚并[1,2-b]喹啉-3,15-二酮:
将5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-5-羟基-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮(300mg)、Boc-Gly-OH(923 mg,7eq.)和4-(二甲基氨基)吡啶(DMAP)(560.4mg,6eq.)溶于DCM和DMF(30 mL,v/v,30/0.5)的混合溶剂中。然后,加入1-(3-二甲氨基丙基)-3-乙基碳二酰亚胺(EDC)(1.08g,7.5eq.)。室温下,搅拌混合物过夜,减压除去溶剂。将残余物溶于100mLDCM中,相继用10%柠檬酸水溶液(20mL× 2)、饱和NaHCO3溶液(20mL×2)和饱和盐水(10mL×3)洗涤。有机层用MgSO4干燥,过滤、减压蒸发去除溶剂。用硅胶柱快速色谱纯化粗产物,流动相为含10%甲醇的DCM,得到纯品5-O-tBoc-甘酰胺-5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮330mg,TLC(硅胶,DCM/MeOH:9/1):Rf=0.43。电喷雾离子质谱(ESI MS)分析得到分子量为556.4(与计算的分子量555.5相符)。
实施例9
5-O-甘氨酰-5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮三氟乙酸盐
在氮气氛围下,用30%三氟乙酸(TFA)的DCM溶液处理5-O-叔丁基-甘氨酰-5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮(330mg)1个小时。减压下,除去TFA和溶剂。加冷乙醚研磨残余物,得到微黄色粉末。TLC(硅胶,DCM/MeOH:9/1):Rf=0.13。ESI MS分析得到的分子量为456.0(与计算的分子量455.4相符)。
实施例10
5-O-(N-戊二酰-甘氨酰)-5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮
将5-O-甘氨酰-5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮(208mg,0.37mmol)、戊二酸酐(66mg,0.58mmol,1.5eq.)和三乙胺(243mL)混合物的DMF(7mL)溶液在室温下搅拌3个小时。减压蒸除溶剂。残余物溶于水(10mL)中,0℃下,加入0.5N HCl调节溶液的pH值至3。将产生的沉淀滤出,用冷水和醚洗涤。减压干燥,得到固体160mg。收率为77%。ESI MS分析得出分子量为570.0(与计算出的分子量569.5相符)。HPLC分析的纯度为98%。
实施例11
5-O-(N-琥珀酰-甘氨酰)-5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮
基本按照实施例10的方法,利用琥珀酸酐合成标题化合物。收率为86%。ESI MS分析得出分子量为556.2(与计算的分子量555.50相符)。HPLC分析的纯度为96%。
实施例12
喜树碱-20-(S)-[O-(Boc-甘氨酰)]
将喜树碱(0.79 g,2.2 mmol)、Boc-Gly-OH(1.2 g,6.8mmol,3eq.)和DMAP(0.83g,6.8mmol,3eq.)溶于DCM和THF的混合溶剂(18mL,v/v,5/1)中。在冰水浴中冷却该混合物。然后加入1,3-二异丙基碳二酰亚氨(DIC)(1.1mL,6.8mmol,3.1eq.),0℃下搅拌0.5个小时,将混合物升温至室温,然后搅拌过夜。用50mLDCM稀释该溶液,然后相继用10%柠檬酸水溶液(20 mL x 2)、饱和NaHCO3(20mL×2)和饱和盐水(10mL×3)洗涤。有机层用MgSO4干燥,过滤,滤液减压浓缩。得到粗产物,用硅胶快速分离色谱纯化,流动相为含4%甲醇的DCM,纯化得纯品喜树碱-20-(S)-(O-tBoc-甘氨酰)(1.07 g,白色固体)。TLC(硅胶,DCM/MeOH:9/1):Rf=0.6。MS ESI分析得出的分子量为506.3(与计算的分子量505.53相符)。
实施例13
喜树碱-20-(S)-(O-甘氨酰)三氟乙酸盐
氮气氛围下,用含50%TFA的DCM处理喜树碱-20-(S)-[O-(Boc-甘氨酰)](1.07g,2.1mmol)达1个小时。减压除去TFA和溶剂。用冷乙醚研磨残余物,形成沉淀,过滤,用冷乙醚洗涤固体,得到微黄色粉末(0.9 g,1.78 mmol)。收率为83%,TLC(硅胶,DCM/MeOH:9/1):Rf=0.23。ESI MS分析得出分子量为406.2(与计算的分子量405.41相符)。
实施例14
喜树碱-20-(S)-[O-(N-琥珀酰-甘氨酰)]
在室温下搅拌喜树碱-20-(S)-(O-甘氨酰)三氟乙酸盐(0.9 g,1.7mmol),琥珀酸酐(0.35g,3.5mmol,2eq.)和三乙胺(0.72mL,3eq.)在DMF(10mL)中的混合物达5分钟。过滤、收集生成的沉淀。将收集到的固体悬浮于冷水(10mL)中。加入5%柠檬酸水溶液调节水悬浮液的pH值至2。0℃下搅拌0.5小时,滤出沉淀,用冷水和醚洗涤沉淀,减压干燥固体,得到产物0.88 g(1.58 mmol)。收率为99%。ESI MS分析的分子量为505.7(与计算出的分子量505.49相符)。HPLC分析的纯度为99%。
实施例1 5
喜树碱-20-(S)-[O-(N-戊二酰基-甘氨酰)]
用戊二酸酐基本按照实施例14所述的方法合成标题化合物。收率为75%。ESI MS分析的分子量为520.5(与计算的分子量519.52相符)。HPLC分析的纯度为98%。
实施例16
喜树碱-20-(S)-[O-(Boc-缬氨酰基)]
0℃下,在喜树碱(350mg)和DMAP(180mg)的DCM(10mL)的溶液中加入Boc-Val-F(2eq.)的DCM溶液,Boc-Val-F是采用文献记载的方法(Carpino etal.,J.Org.Chem.,56,2611,1991)制备的。0-5℃下搅拌30分钟,将混合物升温至室温,并连续搅拌过夜。用氯仿(30mL)稀释混合物,用水、10%柠檬酸水溶液和饱和的NaHCO3洗涤,用MgSO4干燥,然后过滤。减压除去溶剂后,在硅胶柱上纯化残余物,流动相为氯仿/丙酮(9∶1)。将含有目标产物的各部分洗脱液收集起来,然后减压浓缩得到固体。
实施例17
喜树碱-20-(S)-(O-缬氨酰基)三氟乙酸盐
用含35%TFA的氯仿(10mL)溶液处理实施例16所制得的喜树碱-20-(S)-[O-(Boc-缬氨酸基)]达30分钟。减压除去TFA和溶剂,得到固体。ESIMS分析的分子量为448.4(与计算的分子量447.50相符)。
实施例18
喜树碱-20-(S)-[O-(N-琥珀酰-缬氨酰)]
向含有喜树碱-20-(S)-(O-缬氨酰)三氟乙酸盐(150mg)、琥珀酸酐(4eq.)和DMAP(2eq.)的氯仿(10mL)的混合溶液中加入三乙胺(6eq.)。室温搅拌过夜,用氯仿(20mL)稀释反应混合物。用水和柠檬酸水溶液洗涤稀释后的溶液,MgSO4干燥,过滤。减压除去溶剂,加入丙酮研磨残余物成粉状。得到120mg的标题化合物。TLC(硅胶,氯仿/甲醇=9∶1):Rf=0.22。ESI MS分析的分子量为548.2(与计算的分子量547.57相符)。
实施例19
{5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮-5-O-甘氨酰-谷二酰}-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys-)-Thr-NH2
将实施例3的H-(Doc)6-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂(0.196mmol)与实施例10的5-O-(N-戊二酰-甘氨酰)-5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮(0.123 g,0.22mmol,1.1eq.)和DIC(136μL,0.88mmol,4.4 eq.)以及1-羟基-7-氮杂苯并三唑(HOAT)(30mg,0.22mmol,1.1eq.)混合到5mL DCM中。振摇混合物2天。相继用DMF、甲醇和DCM清洗树脂。在空气中干燥后,用TFA、H2O和三异丙基硅烷(TIS)(9.5mL/0.85mL/0.8mL)的混合物处理树脂2个小时。过滤除去树脂,将滤液倒入100mL冷醚中。离心,收集沉淀物。将粗产物溶于100mL的5%AcOH水溶液中,然后向其中逐滴加入碘甲醇溶液,直至溶液保持为黄色。再搅拌反应液1个小时。加入10%Na2S2O3水溶液淬灭过量的碘。用制备HPLC系统纯化溶液中的粗产物,使用的色谱柱为4×43cm的C18DYNAMAX-100A0(Varian,Walnut Creek,CA)。从80%A和20%B至55%A和45%B线性梯度洗脱色谱柱50分钟,其中A为含0.1%TFA的水溶液,B为含0.1%TFA的丙腈溶液。通过分析HPLC检测各部分洗脱液成分。收集含有纯净产物的洗脱液,冻干,收率为25%。分析型HPLC分析的纯度为99.9%。ESI MS分析的分子量为2761.1(与计算的分子量2761.04相符)。
实施例20
{5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮-5-O-甘氨酰-戊二酰}-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19所述的方法合成,利用实施例2的H-Doc-Doc-Doc-Doc-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂合成标题化合物。收率为2 1.4%。分析型HPLC分析的纯度为99.9%。ESI MS分析的分子量为2471.2(与计算的分子量2471.727相符)。
实施例21
{5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮-5-O-甘氨酰-琥珀酰}-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19所述的方法合成,利用实施例11的5-O-(N-琥珀酰-甘氨酰)-5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮和实施例7的H-Aepa-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA Resin合成标题化合物。收率为48%。分析型HPLC分析的纯度为99.9%。ESI MS分析的分子量为1739.8(与计算的分子量1740.14相符)。
实施例22
喜树碱-20-(S)-O-甘氨酰-琥珀酰-Doc-Doc-Doc-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法,利用实施例14的喜树碱-20-(S)-[O-(N-琥珀酰-甘氨酰)]和H-Doc-Doc-Doc-Doc-Aepa-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂合成标题化合物。收率为32%。分析型HPLC分析的纯度为99.9%。ESI MS分析的分子量为2269.0(与计算的分子量2269.8相符)。
实施例23
喜树碱-20-(S)-O-甘氨酰-戊二酰-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法,利用实施例15的喜树碱-20-(S)-[O-(戊二酰-甘氨酰)]和实施例4的H-Aepa-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂,合成标题化合物。收率为11%。分析型HPLC分析的纯度为95%。ESI MS分析的分子量为2008.9(与计算的分子量2009.2相符)。
实施例24
喜树碱-20-(S)-O-缬氨酰-琥珀酰-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法,利用实施例18的喜树碱-20-(S)-[O-(N-琥珀酰-缬氨酰)]和实施例6的H-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂合成标题化合物。得到145mg乳白色固体。ESI MS分析的分子量为1562.4(与计算的分子量1561.8相符)。
实施例25
{5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮-5-O-甘氨酰-琥珀酰}-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法,利用实施例11的{5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮-5-O-(N-甘氨酰-琥珀酰)和实施例6的H-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂合成标题化合物。得到乳白色固体。ESI MS分析的分子量为1570.2(与计算的分子量1569.72相符)。
实施例26
H-Aepa-(Doc)4-Gln(Trt)-Trp(Boc)-Ala-Val-βAla-His(Trt)-Leu-Leu-Rink AmideMBHA树脂
基本按照实施例5的方法合成标题保护的肽-树脂。Fmoc-His(Trt)-OH,Fmoc-Gln(Trt)-OH,Fmoc-Leu-OH,Fmoc-Ala-OH和Fmoc-βAla-OH购自AnaSpec(San Jose,CA)。
实施例27
H-Aepa-(Doc)4-DPhe-Gln(Trt)-Trp(Boc)-Ala-Val-βAla-His(Trt-Leu-Leu-Rink Amide MBHA树脂
基本按照实施例26的方法合成标题保护的肽-树脂。
实施例28
喜树碱-20-(S)-O-甘氨酰-琥珀酰-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
室温下,将DCM(7mL)和DMF(7mL)中的实施例26的H-Aepa-(Doc)4-Gln(Trt)-Trp(Boc)-Ala-Val-βAla-His(Trt)-Leu-Leu-Rink AmideMBHA树脂(0.125mmol)和实施例14的喜树碱-20-(S)-[O-(N-甘氨酰-琥珀酰)](0.138mmol,1.1eq.)以及DIC(0.55mmol,4.4.eq.)和HOBt(0.275mmol,2.2eq.)的混合物振摇5天。用TFA、H2O和TIS(9.5mL/0.85mL/0.8mL)溶液处理2个小时,使肽从树脂上分离。滤除树脂,用二乙醚使肽沉淀。离心悬浮液,得到球形粗产物肽。用制备型HPLC系统纯化粗产物,使用的色谱柱为MicrosorbC18柱,从100%A和0%B至20%A和80%B,线性梯度洗脱80分钟。A为含0.1%TFA的水溶液,B为含0.1%TFA的丙腈溶液。利用分析型HPLC检测各部分洗脱液。收集含有目标产物的洗脱液,冻干。分析型HPLC得到的纯度为96.1%。ESI MS分析的分子量为2172.9(与计算的分子量2173.44相符)。
实施例29
喜树碱-20-(S)-O-甘氨酰-琥珀酰-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
基本按照实施例28的方法合成标题肽。分析型HPLC得到的纯度为99.9%。ESIMS分析的分子量为2321.1(与计算的分子量2320.62相符)。
实施例30
喜树碱-20-(S)-O-甘氨酰-琥珀酰-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His- Leu-Leu-NH2
基本按照实施例28的方法合成标题肽。分析型HPLC得到的纯度为99.9%。ESI MS分析的分子量为1882.8(与计算的分子量1883.13相符)。
实施例31
喜树碱-20-(S)-O-甘氨酰-琥珀酰-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
基本按照实施例28的方法合成标题肽。分析型HPLC得到的纯度为99.9%。ESI MS分析的分子量为2030.7(与计算的分子量2030.30相符)。
实施例32
喜树碱-20-(S)-O-甘氨酰-琥珀酰-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
利用Aepa-(Doc)4-Gaba-Gln(Trt)-Trp(Boc)-Ala-Val-βAla-His(Trt)-Leu-Nle-Rink Amide MBHA树脂,基本按照实施例28的方法合成标题肽。
实施例33
pGlu-His(Trt)-Trp(Boc)-Ser(tBu)-Tyr(tBu)-DLys[Nε-Aepa]-Leu-Arg(Pbf)-Pro-Gly-Rink Amide MBHA树脂
基本按照实施例1的方法合成标题肽-树脂。Fmoc-Arg(Pbf)-OH,Fmoc-Ser(tBu)-OH,Fmoc-His(Trt)-OH,Fmoc-Pro-OH,Fmoc-Gly-OH,Fmoc-Leu-OH,Fmoc-DLys(Dde)-OH购自Novabiochem,San Diego,CA。pGlu-OH购自Chem-Impex Internatoinal,Wood Dale,IL。以0.25mmol的规模合成。用含有20%哌啶的N-甲基吡咯烷酮(NMP)处理30分钟以去除Fmoc基团。得到pGlu-His(Trt)-Trp(Boc)-Ser(tBu)-Tyr(tBu)-DLys(Dde)-Leu-Arg(Pbf)-Pro-Gly-Rink Amide MBHA树脂后,将保护的肽-树脂移至振摇器上的反应瓶内用于人工合成。用含2%肼的DMF溶液处理半个小时去除DLys残基上的Dde保护基。用DMF、MeOH和DCM彻底清洗树脂,然后与预活化的Fmoc-Aepa-OH的酯溶液(如实施例4所述)在含有0.5mL DIEA的DMF溶液中振摇2个小时。用DMF清洗树脂,用含有20%哌啶的DMF溶液处理树脂以去除Aepa残基上的Fmoc保护基。用DMF和DCM彻底清洗保护的肽-树脂。
实施例34
pGlu-His(Trt)-Trp(Boc)-Ser(tBu)-Tyr(tBu)-DLys[Nε-(Aepa-(Doc)4-)]-Leu-Arg(Pbf)-Pro-Gly-Rink Amide MBHA树脂
利用实施例33的pGlu-His(Trt)-Trp(Boc)-Ser(tBu)-Tyr(tBu)-DLys[Nε-Aepa]-Leu-Arg(Pbf)-Pro-Gly-Rink Amide MBHA树脂,基本按照实施例2的方法合成标题保护的肽树脂。
实施例35H-(Doc)4-Aepa-Caeg-DCys(Trt)-3Pal-DTrp(Boc)-Lys(Boc)-DCys(Trt)-Thr(Bzl)-Tyr(tBu)-Rink Amide MBHA树脂
基本按照实施例5的方法合成标题保护的肽树脂。Fmoc-Thr(Bzl)-OH、Fmoc-DCys(Trt)-OH和Fmoc-3Pal-OH源自Chem-Impex Internatoinal,WoodDale,IL。Fmoc-DTrp(Boc)-OH、Fmoc-Lys(Boc)-OH和Fmoc-Tyr(tBu)-OH源自AnaSpec,San Jose,CA。Fmoc-Caeg(Bhoc)-OH源自PepSeptive Biosystems,Framingham,Mass。
实施例36
H-(Doc)4-Aepa-DPhe-Cys(Trt)-3ITyr-DTrp(Boc)-Lys(Boc)-Val-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂
基本按照实施例5的方法合成标题保护的肽树脂。Fmoc-3ITyr-OH和Fmoc-DPhe-OH源自Chem-Impex Internatoinal,Wood Dale,IL。
实施例37
紫杉醇-2’-O-甘氨酰
向Boc-Gly-OH(53mg)和紫杉醇(215mg)的10mL二氯甲烷溶液中,加入4-二甲氨基吡啶(DMAP,10mg),然后加入EDC(58mg)。室温搅拌过夜后,用20mL二氯甲烷稀释反应液,用10%柠檬酸水溶液、饱和的NaHCO3和水洗涤混合物,然后用MgSO4干燥,过滤。减压蒸除滤液中的溶剂。用30%TFA二氯甲烷溶液室温处理粗产物45分钟。减压除去TFA和溶剂,得到固体0.256g。ESI MS分析的分子量为911.0(与计算的分子量911.1相符)。
实施例38
紫杉醇-2’-O-(N-甘氨酰-琥珀酰)
将紫杉醇-2’-O-甘氨酰三氟乙酸盐(127mg,1eq.)和琥珀酸酐(150mg,12eq)在5mL吡啶中的混合物室温搅拌过夜。减压蒸除溶剂。残余物用水研磨1个小时,过滤,收集沉淀物。用水洗涤固体,干燥,得到固体94.8 mg。ESIMS分析的分子量为1010.9与计算的1011.06相符)。
实施例39
紫杉醇-2’-O-(N-缬氨酰-琥珀酰)
利用Boc-Val-OH,基本按照实施例37和38的方法合成标题化合物。ESIMS分析的分子量为1052.5(与计算的分子量1053.27相符)。
实施例40
紫杉醇-2’-O-Gly-琥珀酰-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
将5mL DCM中的H-Aepa-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Rink Amide MBHA树脂(实施例4)(0.1mmol)、紫杉醇-2’-O-(N-甘氨酰-琥珀酰)(实施例39)(1.1eq.)、DIC(136μL,4.4eq.)和HOAT(30mg,1.1eq.)的混合物振摇2天。相继用DMF、甲醇和DCM清洗树脂。空气中干燥后,用TFA、H2O和三异丙基硅烷(TIS)(9.5 mL/0.85 mL/0.8mL)的混合物处理树脂2个小时。滤除树脂,将滤液倒入100 mL冷醚中。离心,收集沉淀。将粗产物溶于混合系统(100mL5%乙酸水溶液和30mL乙腈)中。向该溶液住滴加入碘甲醇直至黄色不再褪去。再搅拌反应液45分钟。加入10%Na2S2O3水溶液以淬灭过量的碘。用制备型HPLC纯化溶液中的粗产物,所用色谱柱为4x43cm的C18DYNAMAX-100A0(Varian,Walnut Creek,CA)。从80%A和20%B至55%A和45%B,线性梯度洗脱50分钟,其中A为含0.1%TFA的水溶液,B为含0.1%TFA的乙腈溶液。通过分析型HPLC检测各洗脱液。收集含有纯净产物的洗脱液,然后冻干。分析型HPLC得到的纯度为98%。ESI MS分析的分子量为2500.9(与计算的分子量2501.0相符)。
实施例41
紫杉醇-2’-O-Val-琥珀酰-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例40的方法合成标题肽。分析型HPLC得到的纯度为99%。ESI MS分析的分子量为2066.2(与计算的分子量2067.4相符)。
实施例42
紫杉醇-2’-O-Val-琥珀酰-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例40的方法合成标题肽。分析型HPLC得到的纯度为95%。ESI MS分析的分子量为2544.3(与计算的分子量2543.9相符)。
实施例43
N-Boc-阿霉素-14-O-(Fmoc-甘氨酸)酯
向DMF(5mL)中的阿霉素-HCl(190mg)溶液加入(BOC)2O(1.2eq),然后加入二乙丙基乙基胺(2.5 eq.)。搅拌3个小时后,减压除去易挥发物质。用水处理残余物。过滤,收集固体,用水洗涤固体,干燥。将所得产物溶于DMF(10mL)中。然后向该DMF溶液中加入Fmoc-Gly-OH(1.2eq.)、DMAP(0.2eq.)和EDC(1.2eq),室温搅拌该混合液4个小时。蒸除溶剂后,残余物在氯仿-甲醇和水之间进行分配。用MgSO4干燥有机层,然后过滤。减压蒸除溶剂,残余物用硅胶色谱进行纯化,流动相为氯仿-甲醇(9∶1)。收集含目标产物的各洗脱液,然后减压蒸除溶剂。
实施例44
N-BOC-阿霉素-14-O-[(N-琥珀酰)甘氨酸]酯
向Boc-阿霉素-14-O-(Fmoc-甘氨酸)酯(100mg)的DMF(5mL)溶液中加入1mL哌啶。室温搅拌2个小时后,用氯仿(20mL)进行稀释。用盐水洗涤混合物,MgSO4干燥,过滤。减压蒸除溶剂至体积为约5mL。向该混合物中加入琥珀酸酐(4eq.)、DMAP(2eq.)和三乙胺(4eq.),然后室温下搅拌该溶液过夜。减压蒸除易挥发物质。用5%柠檬酸水溶液研磨该残余物,然后过滤收集沉淀物,然后用水洗涤沉淀物,最后干燥。
实施例45
pGlu-His-Trp-Ser-Tyr-DLys[-(阿霉素-14-O-甘氨酰-琥珀酰-Aepa-(Doc)4-)]-Leu-Arg-Pro-Gly-NH2
基本按照实施例28的方法,用pGlu-His(Trt)-Trp(Boc)-Ser(tBu)-Tyr(tBu)-DLys[-(Aepa-(Doc)4-)]-Leu-Arg(Pbf)-Pro-Gly-Rink Amide MBHA树脂(实施例34)和Boc-阿霉素-14-O-[(N-琥珀酰)甘氨酸]酯(实施例44)合成标题化合物。
实施例46
pGlu-His-Trp-Ser-Tyr-DLys[-(阿霉素-14-O-Gly-琥珀酰-(Doc)4-Gaba-)-Leu-Arg-Pro-Gly-NH2
基本按照实施例45的方法合成标题化合物。Fmoc-Gaba-OH源自Novabiochem,San Diego,CA。
实施例47
阿霉素-14-O-甘氨酰-琥珀酰-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
基本按照实施例19的方法,用H-(Doc)4-Aepa-Caeg-DCys(Trt)-3Pal-Trp(Boc)-Lys(Boc)-DCys(Trt)-Thr(Bzl)-Tyr(tBu)-Rink Amide MBHA树脂(实施例35)和BOC-阿霉素-14-O-[(N-琥珀酰)甘氨酸]酯(实施例44)合成标题化合物。
实施例48
紫杉醇-2’-O-甘氨酰-琥珀酰-(Doc)4-Aepa-DPhe-cyclo[Cys-3ITyr-DTrp-Lys-Val-Cys]-Thr-NH2
基本按照实施例40的方法,用H-(Doc)4-Aepa-DPhe-Cys(Trt)-3ITyr-DTrp(Boc)-Lys(Boc)-Val-Cys(Trt)-Thr(tBu)-Rink Amide MBHA树脂(实施例36)和紫杉醇-2’-O-(N-甘氨酰-琥珀酰)(实施例38)合成标题化合物。
实施例49
紫杉醇-2’-O-甘氨酰-琥珀酰-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe- Nle-NH2
基本按照实施例28的方法,用H-Aepa-(Doc)2-Gln(Trt)-Trp(Boc)-Ala-Val-βAla-His(Trt)-Phe-Nle-Rink Amide MBHA树脂和紫杉醇-2’-O-(N-甘氨酰-琥珀酰)(实施例38)合成标题化合物。
实施例50
基本按照实施例45的方法,用pGlu-His(Trt)-Trp(Boc)-Ser(tBu)-Tyr(tBu)-DLys[Nε-(Aepa-(Doc)4-)]-Leu-Arg(Pbf)-Pro-Gly-Rink Amide MBHA树脂(实施例34)和2’-O-(N-琥珀酰-甘氨酰)-紫杉醇(实施例38)合成标题化合物。
实施例51
基本按照实施例50的方法,用喜树碱-20-(S)-[O-(N-琥珀酰-甘氨酰)](实施例14)合成标题化合物。
实施例52
基本按照实施例19的方法合成标题化合物。收率=11%,分析型HPLC所得纯度为99.9%。ESI MS分析的分子量为1891.8(与计算的分子量1891.1相符)。
实施例53
喜树碱-Gly-戊二酰-Lys-DTyr-DTyr-环(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=23%,分析型HPLC所得纯度为99%。ESI MS分析的分子量为1841.9(与计算的分子量1841.1相符)。
实施例54
喜树碱-Gly-琥珀酰-(Doc)6-DPhe-c(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=18%,分析型HPLC所得纯度为98%。ESI MS分析的分子量为2390.0(与计算的分子量2390.7相符)。
实施例55
喜树碱-Gly-戊二酰-Lys-Lys-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=12%,分析型HPLC所得纯度为100%。ESI MS分析的分子量为2097.0(与计算的分子量2097.4相符)。
实施例56
喜树碱-Gly-琥珀酰-(Doc)4-DPhe-c(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例1 9的方法合成标题化合物。收率=31%,分析型HPLC所得纯度为100%。ESI MS分析的分子量为2100.9(与计算的分子量2100.3相符)。
实施例57
喜树碱-Gly-琥珀酰-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=21%,分析型HPLC所得纯度为97%。ESI MS分析的分子量为1688.0(与计算的分子量1688.9相符)。
实施例58
喜树碱-Abu-琥珀酰-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=23%,分析型HPLC所得纯度为95%。ESI MS分析的分子量为2435.2(与计算的分子量2435.8相符)。
实施例59
喜树碱-戊二酰-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=11%,分析型HPLC所得纯度为95%。ESI MS分析的分子量为2074.0(与计算的分子量2074.4相符)。
实施例60
喜树碱-戊二酰-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=16%,分析型HPLC所得纯度为95%。ESI MS分析的分子量为1929.5(与计算的分子量1929.2相符)。
实施例61
喜树碱-20-甘氨酰-琥珀酰-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=15.6%,分析型HPLC所得纯度为94%。ESI MS分析的分子量为1520.1(与计算的分子量1519.71相符)。
实施例62
{5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮-5-O-甘氨酰-琥珀酰}-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=25%,分析型HPLC所得纯度为97%。ESI MS分析的分子量为2320.0(与计算的分子量23 19.6相符)。
实施例63
{5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮-5-O-甘氨酰-戊二酰}-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=24%,分析型HPLC所得纯度为95%。ESI MS分析的分子量为2059.4(与计算的分子量2060.3相符)。
实施例64
(5-(R)-乙基-9,10-二氟-1,4,5,13-四氢-3H,15H-氧杂卓并[3’,4’:6,7]中氮茚并[1,2-b]喹啉-3,15-二酮-5-O-甘氨酰-琥珀酰}-(Doc)4-Aepa-Lys-DTyr-DTyr-c(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=48%,分析型HPLC所得纯度为99.9%。ESI MS分析的分子量为2626.0(与计算的分子量2626.9相符)。
实施例65
喜树碱-20-戊二酰-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
基本按照实施例19的方法合成标题化合物。收率=10%,分析型HPLC所得纯度为98.9%。ESI MS分析的分子量为2365.0(与计算的分子量2365.0相符)。
实施例66
H-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Aloc)-Abu-Cys(Trt)-Thr(tBu)-Rink-Amide-MBHA-树脂
基于芴甲氧羰基(Fmoc)化学保护方法,用应用生物系统(Foster City,CA)433A型肽合成仪自动合成标题肽。使用0.72 mmol/g取代的Rink AmideMBHA树脂(Novabiochem,San Diego,CA)。采用的Fmoc氨基酸(AnaSpec,SanJose,CA)具有如下侧链保护:Fmoc-Thr(tBu)-OH,Fmoc-Cys(Trt)-OH,Fmoc-Lys(Aloc)-OH,Fmoc-DTrp(Boc)-OH,Fmoc-Tyr(OtBu)-OH,Fmoc-DPhe-OH和Fmoc-Abu-OH。以0.25 mmol规模进行合成。用含20%哌啶的N-甲基吡咯烷酮(NMP)溶液处理30分钟去除Fmoc基团。在各偶联步骤中,首先将Fmoc氨基酸(4eq,1mmol)在含有0.45M 2-(1-H-苯并三唑-1-基)-1,1,2,3-四甲基脲鎓六氟磷酸酯/1-羟基-苯并三唑(HBTU/HOBT)的DMF溶液中预活化。将得到的活化氨基酸酯、1mL二异丙基乙基胺(DIEA)和1mLNMP加到树脂中。设定ABI433A肽合成仪的程序进行下列反应循环:(1)用NMP清洗,(2)用含20%哌啶的NMP溶液处理30分钟,去除Fmoc保护基,(3)用NMP清洗,(4)与预先活化的Fmoc氨基酸偶联1个小时。对于Cys(Trt)2、Tyr(tBu)3和DTrp(Boc)4,采用的是单偶联法。其它氨基酸采用双偶联法。根据序列将残基逐个偶联到树脂上。肽链偶联完毕后,去除Fmoc,用DMF和二氯甲烷(DCM)彻底清洗树脂。
实施例67
Fmoc-Aepa-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Aloc)-Abu-Cys(Trt)-Thr(tBu)-Rink-Amide-MBHA-树脂
从实施例66的肽开始合成标题肽。将Fmoc-Aepa-OH(NeosystemLaboratoire,Gennevilliers,France.1.5eq,0.75mmol)用含有O-(7-氮杂苯并三唑-1-基)-1,1,3,3-四甲基脲鎓六氟磷酸酯(HATU,1.4eq,0.7mmol)和1-羟基-7-氮杂苯并三唑(HOAT,1.4eq.,0.7mmol)的2mL DMF溶液预活化5分钟。将上述树脂移至小反应瓶中,并与活化的Fmoc-Aepa-OH的酯以及1mL DIEA一同在振摇器上振摇2个小时。用DMF和DCM彻底清洗树脂。
实施例68
H-Doc-Doc-Doc-Doc-Aepa-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Aloc)-Abu-Cys(Trt)-Thr(tBu)-Rink-Amide-MBHA-树脂
从实施例68的肽开始合成标题肽。用DMF清洗树脂后,用含25%哌啶的DMF溶液处理树脂,除去Fmoc。该树脂与Fmoc-Doc-OH(Chem-ImpexInternatoinal,Wood Dale,IL.,1.5eq,0.75mmol)、N,N-二异丙基碳二酰亚胺(DIC,1.5eq,0.75mmol)和HOBT(1.5eq,0.75mmol)的DMF溶液混合2个小时。如偶联第一个Fmoc-Doc-OH的相同方法,将第2至第4个Fmoc-Doc-OH偶联到树脂上。重复该方法直至肽链完成偶联。
用含25%哌啶的DMF溶液除去Fmoc。用DMF和DCM清洗树脂。
实施例69
H-Doc-Doc-Doc-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys(Aloc)-Abu-Cys)-Thr-NH2
用19mL TFA(三氟乙酸,Halocarbon Products Corp.River Edge,NJ)、1.6mL TIS(三异丙基硅烷,Aldrich)和1.7mL水将肽从树脂上切断,进行2个小时。滤除树脂,将肽倾入醚中得到沉淀。将沉淀物溶于150 mL的5%醋酸和30mL的乙腈中。逐滴加入碘(20mg/ml,在MeOH中)直至红色不再褪去。将烧瓶置于热水浴中,搅拌2个小时。用10%Na2SSO3淬灭该反应。用PhenomenexC18色谱柱纯化所得肽,用5-60%CH3CN进行梯度洗脱,其中,Buffer A是含0.1%TFA的水溶液,Buffer B是含0.1%TFA的CH3CN溶液,洗脱60分钟以上。将含有产物的洗脱部分冻干,得到186mg(收率:40%)的白色粉末。MS(电喷雾):1722.2。
实施例70
H-Doc-Doc-Doc-Aepa-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Aloc)-Abu-Cys(Trt)-Thr(tBu)-Rink-Amide-MBHA-树脂
从实施例67的肽开始合成标题肽。用DMF清洗树脂后,用含25%哌啶的DMF溶液处理树脂,除去Fmoc。该树脂与Fmoc-Doc-OH(Chem-ImpexInternatoinal,Wood Dale,IL,1.5eq,0.75mmol)、N,N-二异丙基碳二酰亚胺(DIC,1.5eq,0.75mmol)和HOBT(1.5eq,0.75mmol)的DMF溶液混合2个小时。如偶联第一个Fmoc-Doc-OH的相同方法,将第2至第3个Fmoc-Doc-OH偶联到树脂上。重复该方法直至肽链完成偶联。用含25%哌啶的DMF溶液除去最后的Fmoc。用DMF和DCM清洗树脂。
实施例71
H-Doc-Doc-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys(Aloc)-Abu-Cys)-Thr-NH2用19mL TFA(三氟乙酸,Halocarbon Products Corp.River Edge,NJ)、1.6mLTIS(三异丙基硅烷,Aldrich)和1.7mL的水将肽从树脂上切断,进行2个小时。滤除树脂,将肽倾入醚中得到沉淀。将沉淀物溶于150 mL的5%醋酸和30mL的乙腈中。逐滴加入碘(20mg/ml,在MeOH中)直至红色不再褪去。将烧瓶置于热水浴中,搅拌2个小时。用10%Na2SSO3淬灭该反应。用PhenomenexC18色谱柱纯化所得肽,用5-60%CH3CN进行梯度洗脱,其中,Buffer A是含0.1%TFA的水溶液,Buffer B是含0.1%TFA的CH3CN溶液,洗脱60分钟以上。将含有产物的洗脱部分冻干,得到180mg(收率:42%)的白色粉末。MS(电喷雾):1722.2。
实施例72
紫杉醇-2’-戊二酸
向紫杉醇(HandeTech USA,Inc,Houston,Texas,1g.,1.17mmol)的吡啶(10mL)溶液加入戊二酸酐(Aldrich,1.6 g,14.1mmol,12eq.)。室温下搅拌该溶液4个小时,然后减压蒸馏。加入20ml的水。过滤,得到粘性固体。用丙酮/水重结晶,得到0.842 g的白色固体,0.869mmole,收率:74%。MS(电喷雾):969.0。
实施例73
紫杉醇-2’-Doc-Suc-OH
在紫杉醇(1g.,1.17mmol)和Boc-Doc-OH(0.31g.,1.17mmol)的DCM(25mL)溶液中,加入DIC(0.241mL,1.54mmol),然后加入DMAP(50mg.0.4mmol)。所得溶液在室温下搅拌4个小时。用3X10%柠檬酸、3X饱和的NaHCO3、1x饱和的NaCl洗涤所得溶液,用MgSO4干燥。过滤,蒸馏。将所得残余物溶于EtOAc中,然后用正己烷进行沉淀。过滤,得到沉淀的产物,减压干燥,得到固体(1.19g,1.08mmol)。收率为92%。MS(电喷雾):m/e=1099.7(+1),HPLC所分析的纯度为95%。将得到的Boc-Doc-紫杉醇(1.19g,1.08mmol)溶于20mL的甲酸中,搅拌30分钟,然后蒸馏。将产物溶于15mL的吡啶中。向该溶液加入琥珀酸酐(1.29g,13mmol)。室温下搅拌混合物过夜,减压蒸除吡啶。加水研磨使残余物成粉末,收集到0.99g(0.91mmole,收率:84%)。MS(电喷雾)1099.4(+1),1121.6(Na+1)。HPLC分析的纯度为75%。
实施例74
紫杉醇-2’-戊二酰-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
向实施例69的肽(125mg,0.067mmol)的DMF(10mL)溶液中,加入紫杉醇-2’-Glut-OH(实施例72,65mg,0.067mmol)、HOBT(20mg,0.147mmool、BOP(苯并三唑-1-基-氧-三(二甲基氨基)-磷鎓六氟代磷酸盐,Benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium hexafluorophosphate;29mg,0.067mmol)和DIEA(8eq.,93μL)。搅拌所得溶液过夜,然后减压蒸除溶剂。将残余物溶于最小量的MeOH中,然后加醚产生沉淀,得到固体(108 mg,0.04mmol)。收率为60%。MS(电喷雾):1409.5(+2)。为了除去Lys上的Aloc,将肽溶于DCM/THF(无水,15mL/5mL)中,然后,0℃下,加入冰醋酸(15μL,5eq.)、Pd(PPh3)4(四(三苯基膦)钯,Tetrakis(triphenylphosphine)palladium(O);12mg,0.3 eq.)和Bu3SnH(氢化三丁基锡,Tributyltin hydride;2×31μL,3eq)。搅拌1个小时,用含0.5M HCl的醚(0.7mL,10eq.)淬灭该溶液的反应。加醚使肽沉淀。用PLRP-S柱(Polymer Labs,100A,8μ)纯化粗产物,5-90%梯度洗脱1个小时,其中溶剂A是含5%MeOH的水溶液,溶剂B是CH3CN。合并纯净组分,冻干,得到42mg的肽。MS(电喷雾):2731.4(与计算的分子量2732.1相符)。HPLC分析的纯度为99.9%。
实施例75
紫杉醇-2’-Doc-Suc-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
向实施例71的肽(200mg,0.12mmol)的DMF(10ml)溶液中加入紫杉醇-2’-Doc-Suc-OH(实施例73,140mg,0.128mmol)、HOBT(39mg,0.281mmol)、BOP(74mg,0.166mmol)和DIEA(8eq.,177μL)。搅拌该溶液过夜。减压蒸馏。得到固体(355mg,0.126mmol)。
为了除去Lys上的Aloc,将产物溶于DCM/THF(无水,15mL/5mL)中,然后,0℃下,加入冰醋酸(19μL,5eq.)、Pd(PPh3)4(12mg,0.3eq.)和Bu3SnH(2×54μL,3eq)。搅拌1个小时,然后用含0.5M HCl的醚(0.7mL,10eq.)淬灭该溶液的反应。加醚使产物沉淀。用PLRP-S柱(Polymer Labs,100A,8μ)纯化粗产物,5-90%梯度洗脱1个小时,其中溶剂A是含5%MeOH的水溶液,溶剂B是CH3CN。合并纯净组分,冻干。MS(电喷雾):2717.3(与计算的分子量2718.1相符)。HPLC分析的纯度为99.9%。
实施例76
紫杉醇-Sar-Suc-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
用2’-O-(N-琥珀酰-N-甲基-甘氨酰)-紫杉醇(实施例38)和H-Doc-Doc-Doc-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys(Aloc)-Abu-Cys)-Thr-NH2(实施例69),基本按照实施例28的方法合成标题化合物。收率为18.8%,HPLC分析的纯度为95%。分子量为2789.2。
实施例77
紫杉醇-Suc-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
基本按照实施例28的方法,用紫杉醇-2’-琥珀酰(如实施例72中制备的),琥珀酸酐代替戊二酸酐以及基本按照实施例1方法制备的肽H-Doc-Doc-Doc-Doc-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2合成标题化合物,然后如实施例2所述的方法偶联4个Doc残基。收率为12.1%,HPLC分析的纯度为97%。测定的分子量为2537.8。
实施例78
紫杉醇-Sar-Suc-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
基本按照实施例28的方法,用紫杉醇-2’-O-(N-琥珀酰-N-甲基-甘氨酰)(基本上如实施例38的制备),用Boc-Sar-OH代替Boc-Gly-OH以及如实施例1的方法合成的肽H-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2合成标题化合物。然后,如实施例4所述偶联一个Aepa残基,再如实施例5所述偶联4个Doc残基。收率为13.4%,HPLC分析的纯度为98%。测定的分子量为2778.1。
实施例79
喜树碱-Gly-Suc-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
基本上按照实施例28的方法,用喜树碱-20-(S)-[O-(N-琥珀酰-甘氨酰)](实 施例14)和H-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2(实施例 78)合成标题化合物。收率为14.4%,HPLC分析的纯度为99.4%。测定的分子量为2258。
Table(表)A-I中的其他化合物可根据上述方法进行合成。
TABLE A
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Lau-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Lau-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Lau-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-H is-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-G ln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Lau-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Lau-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-H is-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-G ln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-Ala-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Ala-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Vall-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
TABLE B
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Th r-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DP he-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)8-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKFLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKFLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-G ln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-A la-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-G ln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-N le-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
TABLE C
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-H is-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-G ln-Trp-A la-Va l-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Lau-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Th r-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DP he-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DP he-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
TABLE D
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-N H2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gl n-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2N H)-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-Aepa-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Lys--DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-Lys-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)8-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
TABLE E
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKFLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKFLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)8-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DAla-Gln-Trp-Ala-Var-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Va l-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-A la-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-N H2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
TABLE F
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Ala-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-G ln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-(Doc)HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-(Doc)HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-(Doc)HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
TARLF G
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3 ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITy卜DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITy卜DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTy r-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Doc-Caeg-cyclo(DCys-3 Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-(Doc)HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-(Doc)HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-(Doc)HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Aepa)2-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Aepa)2-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
TABLE H
-Suc-(Doc)3-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-Aepa-(Doc)3-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-N H2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Aepa)2-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Aepa)2-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trprp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Va l-Gly-His-Leu-Leu-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
TABLE I
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH4
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclc(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
生物学测试
生长抑素受体-放射性配体的结合实验
体外受体结合试验的细胞膜的制备:在冰冷却的50mM Tris-HCl中,匀化(Polytron setting 6,15秒)表达人类生长抑素受体亚型(hSSTR-1,hSSTR-2,hSSTR-3,hSSTR-4,或hSSTR-5)的CHO-K1细胞,39,000g(10分钟)下离心两次,再重新悬浮于新鲜的缓冲液中。将得到的小球再悬浮于10mM Tris-HCl以备用于结合实验中。为进行hSSTR-1,hSSTR-3和hSSTR-4的结合实验,将等份的细胞膜制备物与含BSA(0.2%)和0.05 nM[125I-Tyr11]SRIF-14的50mMHEPES(pH7.4)、MgCl2(5mM)一起温育(90分钟/25℃)。进行实验的最终体积为0.3ml。为进行hSSTR-2和hSSTR-5的结合试验,分别将[125I]-[4-(2-羟乙基)]-1-哌嗪乙酰基-DPhe-环(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2(0.05 nM)和[125I]-DPhe-环(Cys-Tyr-DTrp-Lys-Val-Cys)-Thr-NH2作为放射性配体,温育时间为90分钟/25℃。利用Brandel filtration manifold通过GF/C滤器快速过滤(预先浸在0.3%聚氮丙啶硫化物中)终止温育。然后用等份的5ml冰冷却的缓冲液清洗各管和滤器,各清洗三次。特异性结合被定义为全部放射性配体结合物减去存在有1000nM SRIF-14(用于hSSTR-1,hSSTR-3,hSSTR-4或hSSTR-5的受体结合试验)的结合物的差值或减去存在有1000nMDPhe-c(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2(用于hSSTR-2受体结合实验)的结合物的差值。
体外生长实验
将培养的CHO-K1细胞或表达hSSTR-2受体的CHO-K1细胞接种于塑料24孔培养板中,培养板中含10%牛胎血清(FBS)的RPMI1640培养基(DMEM),接种密度为约104个细胞/孔/1.0ml,进行体外增殖试验。将测试用的肽以所需浓度加入其中,培养(5%CO2,37℃,潮湿空气)1-3天。用无血清的RPMI基质洗涤细胞,使细胞胰蛋白酶化,再次悬浮于RPMI1640(+10%FBS)中,用Coulter计数器,在1∶20的稀释度下计细胞数。
LHRH放射性配体的结合
用于放射性配体结合研究的细胞膜的制备如下:在20ml冰冷却的50mMTris-HCl中,用Brinkman Polytron(Westbury,NY;setting 6,15秒)匀化表达大鼠重组LHRH受体的CHO-K1细胞。通过离心(39,000g/10分钟),洗涤匀化物两次,得到的小球再次悬浮于含5mM MgCl2和0.1%BSA(牛血清白蛋白)的50mM Tris-HCl中。将等份(0.4ml)细胞膜制备物与其中含有或不含有0.05ml未标记的竞争性测试肽的0.05 nM[125I]D-Trp6 LHRH(2200 Ci/mmol)一起温育,进行结合测试实验。温育60分钟(4℃)后,,通过预先浸入0.5%聚乙烯亚胺/0.1%BSA中的GF/B过滤器(Brandel,Gaithersburg,MD)进行快速过滤,将结合物[125I]D-Trp6LHRH与游离物分离开。然后用等份的5ml冰冷却的50mMTris-HCl清洗过滤器三次,利用γ光谱(Wallac LKB,Gaithersburg,MD)计算捕获在过滤器上的结合物的放射性。特异性结合被定义为全部[125I]D-Trp6LHRH结合物减去存在有1000nM D-Trp6 LHRH(Bachem,Torrence,CA)的结合物之差值。
铃蟾肽/GRP放射性配体的结合
用于放射性配体结合研究的细胞膜的制备如下:在20ml冰冷却的50mMTris-HCl中,用Brinkman Polytron(Westbury,NY;setting 6,15秒)匀化表达天然铃蟾肽/GRP受体的AR42J大鼠胰腺细胞。通过离心(39,000 g/10分钟),洗涤匀化物两次,得到的小球再次悬浮于含2.5 mM MgCl2和0.1%BSA的50mMTris-HCl中。将等份(0.4ml)细胞膜制备物与其中含有或不含有0.05ml未标记的竞争性测试肽的0.05nM[125I-Tyr4]铃蟾肽(2200Ci/mmol,New EnglandNuclear,Boston,MA)一起温育,进行结合测试实验。温育30分钟(4℃)后,通过预先浸入0.3%聚乙烯亚胺中的GF/B过滤器(Brandel,Gaithersburg,MD)来进行快速过滤,将结合物[125I-Tyr4]铃蟾肽与游离物分离开。然后用等份的5ml冰冷却的50mM Tris-HCl清洗过滤器三次,利用γ光谱(Wallac LKB,Gaithersburg,MD)计算捕获在过滤器上的结合物的放射性。特异性结合被定义为全部[125I-Tyr4]铃蟾肽结合物减去存在有1000 nM铃蟾肽(Bachem,Torrence,CA)的结合物之差值。
本发明的一些化合物至少有一个不对称中心。根据分子的不同取代基可能还存在其它不对称中心。每个不对称中心将产生两个光学异构体,所有光学异构体,无论是分离后的、纯化的或部分纯化的光学异构体、外消旋混合物或非对应异构体混合物,都包括在本发明范围之内。
本发明的化合物通常是以药学上可接受的酸加成盐形式提供,如由无机酸和有机酸得到的盐。这些酸得实例包括盐酸、硝酸、硫酸、磷酸、甲酸、乙酸、三氟乙酸、丙酸、马来酸、琥珀酸、D-酒石酸、L-酒石酸、丙二酸、甲磺酸等。此外,含有酸官能团如羧基的化合物,可以以它们的无机盐形式分离出,其中反离子可以选自钠、钾、锂、钙、镁等,以及有机碱。
药学上可接受的盐可以如此形成,将约1当量的本发明的化合物与约1当量或更多的预期盐的适宜的相应酸相接触。制备盐的操作和盐的分离是本领域普通技术人员所公知的方法。
本发明的化合物的给药形式可以是口服、胃肠外给药(如,肌内、腹膜内、静脉内或皮下的注射或灌输)、鼻腔内、阴道内、直肠内、舌下或局部(topical)途径给药,也可与药学上可接受的载体一同制成适于各种给药途径的剂型。因此,本发明描述了药物组合物,其包括作为活性成分的至少一种本发明的化合物以及药学上可接受的载体。
口服固体剂型包括胶囊、片剂、丸剂、粉剂和颗粒剂。这些固体剂型中,活性化合物与至少一种惰性的药学上可接受的载体混合,这些载体为如蔗糖、乳糖或淀粉。这些剂型还可包括,如常规操作所包括的惰性稀释剂之外还包括其它物质,如诸如硬脂酸镁的润滑剂。在胶囊、片剂和丸剂的剂型中还可包括缓冲剂。片剂和丸剂还可用肠溶衣制备。
口服液体剂型包括药学上可接受的乳剂、溶液、悬浮剂、糖浆、酊剂,这些剂型含有本领域常用的惰性稀释剂,如水。除惰性稀释剂以外,组合物还可包括辅料,如润湿剂、乳化剂和悬浮剂、甜味剂、轿味剂和芳香剂。
本发明的胃肠外给药的制剂包括无菌的水性或非水溶液、悬浮液或乳液。非水溶剂或载体的实例为丙二醇、聚乙二醇、植物油,如橄榄油和玉米油、凝胶和可注射的有机酯,如油酸乙酯。这些剂型还可包括辅料,如防腐剂、润湿剂、乳化剂和分散剂。它们可通过利用过滤器滤除细菌、将无菌物质加入组合物中、照射组合物或加热组合物的方法实现无菌化。它们还可以制成无菌固体组合物,这样的无菌固体组合物可以在使用前溶于无菌水或其它无菌可注射溶煤中。
直肠或阴道内给药的组合物优选为栓剂,其可包括,除活性物质以外的赋形剂,如可可油或栓剂蜡。
鼻内或舌下给药的组合物可与本领域的常规赋形剂一同制备。
通常,本发明组合物中的有效量的活性成分是可变的,但活性成分的量与适宜的剂型相对应。所选择的剂量依据需要的治疗效果,依据给药途径,依据治疗时间而定,所有这些因素都是本领域普通技术人员能够驾驭的。通常,施用于人类和其它动物,如哺乳动物的剂量水平为每日0.0001-100mg/kg体重。
优选的剂量范围是0.01-10.0mg/kg体重。这样的剂量可以每日单次给药,或分多次给药。
其它实施方式
不背离本发明的范围和精神下,本发明的上述方法和体系的各种变化和调整都是本领域技术人员显而易见的。尽管结合了具体实施例对本发明进行了描述,可以理解,本发明不应该仅限于这些具体实施例。实施本发明时对所描述方式进行的对于医学、免疫学、药理学、内分泌学或相关领域的技术人员而言是显而易见的各种改变都在本发明的保护范围内。
说明书中所引的公布申请都全文引用于此。
Claims (27)
1.式(I)的化合物或其药学上可接受的盐:
X-B1-B2-B3-B4-Z
(I)
其中:
X是细胞毒物质或细胞抑制剂;
B1,B2,B3和B4各自独立地是(Doc)m,(Aepa)n,-(C(O)-A1-A2-A3-A4-A5-C(O))s-或(氨基酸)p,
A1和A5各自独立地是CR1R2;
R1和R2各自独立地是H,F,Br,Cl,I,C(1-30)烷基,C(2-30)烯基,取代的C(1-30)烷基,取代的C(2-30)烯基,SR3,S(O)R4或S(O)2R5,或R1和R2共同形成C(3-30)环烷基,C(3-30)杂环基或C(5-30)芳环;
R3,R4和R5各自独立地是C(1-30)烷基,C(2-30)烯基,取代的C(1-30)烷基,取代的C(2-30)烯基;
A2,A3和A4各自独立地是CR6R7,O,S,(CH2)t或缺省;
R6和R7各自独立地是H,F,Br,Cl,I,C(1-30)烷基,C(2-30)烯基,取代的C(1-30)烷基,取代的C(2-30)烯基,SR3,S(O)R4或S(O)2R5;或R6和R7共同形成环系;
m独立地是0,1,2,3,4,5,6,7,8,9或10;
n独立地是0,1,2,3,4,5,6,7,8,9或10;
p独立地是0,1或2;
s独立地是1,2,3,4或5;
t各自独立地是0,1,2或3;
Z是生物受体的配体、其类似物或所述配体或所述类似物的衍生物;条件是:
当X是多柔比星或多柔比星衍生物时,至少m和n之一不为0;且
当X是紫杉醇或紫杉醇衍生物时,B1是(氨基酸)p,其中p为1或2。
2.根据权利要求1所述的化合物,其中,X是细胞毒部分,或其药学上可接受的盐。
3.根据权利要求2所述的化合物,其中X是蒽环霉素或其药学上可接受的盐。
4.根据权利要求3所述的化合物,其中X是多柔比星或多柔比星衍生物或它们的药学上可接受的盐。
5.根据权利要求2所述的化合物,其中X是喜树碱、喜树碱衍生物、紫杉醇或紫杉醇衍生物。
9.根据权利要求1-8任意一项所述的化合物,其中,Z是生长抑素、铃蟾肽或LHRH或它们的类似物,或所述配体的衍生物或衍生物的类似物,或它们的药学上可接受的盐。
10.根据权利要求9所述的化合物,其中Z是下式的生长抑素类似物:
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2;
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2;
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2;
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2;
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2;
-Caeg-cyclo(DCys-Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2;
-D2Nal-cyclo[Cys-Tyr-DTrp-Lys-Val-Cys]-Thr-NH2;
-DPhe-cyclo[Cys-Phe-DTrp-Lys-Thr-Cys]-Thr-ol;
-cyclo({4-(-NH-C2H4-NH-CO-O)Pro}-Phg-DTrp-Lys-Tyr(4-Bzl)-Phe);或
-DPhe-cyclo[Cys-Tyr-DTrp-Lys-Val-Cys]-Trp-NH2;或它们的药学上可接受的盐。
11.根据权利要求9所述的化合物,其中,Z是下式的LHRH类似物:
Glp-His-Trp-Ser-Tyr-DLys(-)-Leu-Arg-Pro-Gly-NH2;
Glp-His-Trp-Ser-Tyr-DOrn(-)-Leu-Arg-Pro-Gly-NH2;
Glp-His-Trp-Ser-Tyr-DDab(-)-Leu-Arg-Pro-Gly-NH2;
Glp-His-Trp-Ser-Tyr-DDap(-)-Leu-Arg-Pro-Gly-NH2;
Glp-His-Trp-Ser-Tyr-DApa(-)-Leu-Arg-Pro-Gly-NH2;
Glp-His-Trp-Ser-Tyr-DLys(-)-Leu-Arg-Pro-NHEt;
Glp-His-Trp-Ser-Tyr-DOrn(-)-Leu-Arg-Pro-NHEt;
Glp-His-Trp-Ser-Tyr-DDab(-)-Leu-Arg-Pro-NHEt;
Glp-His-Trp-Ser-Tyr-DDap(-)-Leu-Arg-Pro-NHEt;
Glp-His-Trp-Ser-His-DLys(-)-Trp-Tyr-Pro-Gly-NH2;
Glp-His-Trp-Ser-His-DOrn(-)-Trp-Tyr-Pro-Gly-NH2;
Glp-His-Trp-Ser-His-DDab(-)-Trp-Tyr-Pro-Gly-NH2;或
Glp-His-Trp-ser-His-DDap(-)-Trp-Tyr-Pro-Gly-NH2;或它们的药学上可接受的盐
12.根据权利要求9所述的化合物,其中,Z是下式的铃蟾肽类似物:
-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2;
-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2-NH)-Leu-NH2;
-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2-NH)-Phe-NH2;
-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2;
-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2;
-Gln-Trp-Ala-Val-βAla-Hls-Phe-Nle-NH2;
-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2;
-Gln-Trp-Ala-Val-βAla-Ala-Phe-Nle-NH2;
-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2;
-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2;
-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2;
-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2;
-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-Ala-Phe-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2;
-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2;
-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2-NH)-Leu-NH2;
-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2-NH)-Phe-NH2;
-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2;
-DPhe-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2;
-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2;或它们的药学上可接受的盐。
13.根据权利要求1所述的化合物,其中,至少m和n之一不为零;或这些化合物的药物学上可接受的盐。
18.根据权利要求16所述的化合物,其中,所述化合物包括下式化合物或其药学上可接受的盐:
20.可作为化学合成的中间体的化合物,其中,所述中间体包括下式化合物或它们的有机或无机盐:
H-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA Resin;
H-Doc-Doc-Doc-Doc-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA Resin;
H-Doc-Doc-Doc-Doc-Doc-Doc-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA Resin;
H-Aepa-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA Resin;
H-Doc-Doc-Doc-Doc-Aepa-Lys(Boc)-DTyr(tBu)-DTyr(tBu)-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink Amide MBHA Resin;
H-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-Rink AmideMBHA Resin;
H-Aepa-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Boc)-Abu-Cys(Trt)-Thr(tBu)-RinkAmide MBHA Resin;
H-Aepa-(Doc)4-Gln(Trt)-Trp(Boc)-Ala-Val-βAla-His(Trt)-Leu-Leu-Rink AmideMBHA Resin;
H-Aepa-(Doc)4-DPhe-Gln(Trt)-Trp(Boc)-Ala-Val-βAla-His(Trt)-Leu-Leu-RinkAmide MBHA Resin;
pGlu-His(Trt)-Trp(Boc)-Ser(tBu)-Tyr(tBu)-DLys[Nε-Aepa]-Leu-Arg(Pbf)-Pro-Gly-Rink Amide MBHA Resin;
pGlu-His(Trt)-Trp(Boc)-Ser(tBu)-Tyr(tBu)-DLys[Nε-(Aepa-(Doc)4-)]-Leu-Arg(Pbf)-Pro-Gly-Rink Amide MBHA Resin;
H-(Doc)4-Aepa-Caeg-DCys(Trt)-3Pal-DTrp(Boc)-Lys(Boc)-DCys(Trt)-Thr(Bzl)-Tyr(tBu)-Rink Amide MBHA Resin;
H-(Doc)4-Aepa-DPhe-Cys(Trt)-3ITyr-DTrp(Boc)-Lys(Boc)-Val-Cys(Trt)-Thr(tBu)-Rink Amide MBHA Resin;
H-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Aloc)-Abu-Cys(Trt)-Thr(tBu)-Rink-Amide-MBHA-Resin;
Fmoc-Aepa-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Aloc)-Abu-Cys(Trt)-Thr(tBu)-Rink-Amide-MBHA-Resin;
H-Doc-Doc-Doc-Doc-Aepa-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Aloc)-Abu-Cys(Trt)-Thr(tBu)-Rink-Amide-MBHA-Resin;;or
H-Doc-Doc-Doc-Aepa-DPhe-Cys(Trt)-Tyr(tBu)-DTrp(Boc)-Lys(Aloc)-Abu-Cys(Trt)-Thr(tBu)-Rink-Amide-MBHA-Resin。
21.根据权利要求1所述的化合物,其中,所述化合物包括下式化合物:
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-N le-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-A la-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Va l-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-N H2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-H is-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DT rp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Gys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)8-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKFLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKFLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Ala-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-N H2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Docx)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cycio(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cycio(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cy clo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-N H2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-Aepa-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)X4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Lys--DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-Lys-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)8-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Aepa-Lys-DTyr-DTyr-(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrP-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKFLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKFLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)8-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cycle(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cycle(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Aepa-Lys-DTyr-DTyr-cycle(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cycle(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cycle(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cycle(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cycle(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cycle(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Aepa-Lys-DTyr-DTyr-cycle(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-Gln-T rp-Ala-Val-βAla-His-Leu-Leu-N H2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Glri-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DAla-Gln-Trp Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-H is-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-G ln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-(Doc)HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-(Doc)HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-(Doc)HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Lau-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyDTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Th r(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Th r(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Th r(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
Doc-Aepa-Caeg-cyclo(DCys-3P al-DTrp-Lys-DCys)-Th r(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Va l-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-(Doc)HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-(Doc)HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-(Doc)HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(βzl)-Tyr-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Aepa)2-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Aepa)2-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ(CH2NH)-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-(Doc)3-Aepa-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-Aepa-(Doc)3-Gaba-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-(Doc)3-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-Aepa-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Suc-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Aepa)2-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Aepa)2-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)2-Aepa-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)4-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-(Doc)2-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Ala-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Aepa-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Aepa-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-Aepa-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-(Doc)3-DAla-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-(Doc)3-DPhe-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Leu-Nle-NH2
-Doc-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
-Doc-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
-Doc-Gln-Trp-Ala-Ala-βAla-His-Phe-Nle-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(βAla)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVL(Ava)KRYKQRVKNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQR(A6c)KNK-NH2
-(Aepa)HSDGIFTDSYSRYRKQMA(A5c)KKYLAAVLGKRYKQRVKNK-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Var-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Aepa)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-Doc-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)2-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Aepa)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-Doc-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)2-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Aepa-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQ(Nle)AVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKALNSILN-NH2
-(Aepa)HSDAVFTDNYTRLRKQMAVKKLLNSILN-NH2
-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)2-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyc lo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-(Doc)4-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)6-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-(Doc)6-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)3-Aepa-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)3-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)5-DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2
-Suc-(Doc)3-Aepa-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)3-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)5-DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)3-Aepa-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)3-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)5-Lys-DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2
-Suc-(Doc)3-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)3-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)5-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)4-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)5-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
-Suc-(Doc)4-Aepa-Caeg-cyclo(DCys-3Pal-DTrp-Lys-DCys)-Thr(Bzl)-Tyr-NH2
22.一种包括有效量的权利要求1-21任意一项的化合物或其药学上可接受的盐以及药学上可接受的载体的药物组合物。
23.一种在需要接受治疗的个体上治疗疾病的方法,所述方法包括给予所述个体治疗有效量的权利要求1-21中任意一项的化合物或其药学上可接受的盐,其中所述疾病选自纤维化、良性前列腺增生、动脉硬化、再狭窄、乳腺癌、结肠癌、胰腺癌、前列腺癌、肺癌、小细胞肺癌、卵巢癌、表皮癌和血癌。
24.一种在需要接受治疗的个体上治疗疾病的方法,所述方法包括给予所述个体治疗有效量的权利要求1-21中任意一项的化合物或其药学上可接受的盐,其中所述疾病选自良性前列腺增生、再狭窄、乳腺癌、结肠癌、胰腺癌、前列腺癌、肺癌、小细胞肺癌、卵巢癌、表皮癌和血癌。
25.一种在需要接受治疗的个体上治疗疾病的方法,所述方法包括给予所述个体治疗有效量的权利要求1的化合物或其药学上可接受的盐,其中所述疾病的特征是表达了一种或多种生长抑素型受体的不良细胞增生。
26.一种在需要接受治疗的个体上治疗疾病的方法,所述方法包括给予所述个体治疗有效量的权利要求1的化合物或其药学上可接受的盐,其中所述疾病的特征是表达了一种或多种铃蟾肽型受体的不良细胞增生。
27.一种在需要接受治疗的个体上治疗疾病的方法,所述方法包括给予所述个体治疗有效量的权利要求1的化合物或其药学上可接受的盐,其中所述疾病的特征是表达了一种或多种LHRH型受体的不良细胞增生。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46452803P | 2003-04-22 | 2003-04-22 | |
US60/464,528 | 2003-04-22 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2004800105826A Division CN1777439A (zh) | 2003-04-22 | 2004-04-21 | 生长抑素的载体 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101791409A true CN101791409A (zh) | 2010-08-04 |
Family
ID=33310909
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010003734A Pending CN101791409A (zh) | 2003-04-22 | 2004-04-21 | 肽载体 |
CNA2004800105826A Pending CN1777439A (zh) | 2003-04-22 | 2004-04-21 | 生长抑素的载体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2004800105826A Pending CN1777439A (zh) | 2003-04-22 | 2004-04-21 | 生长抑素的载体 |
Country Status (14)
Country | Link |
---|---|
US (1) | US8709998B2 (zh) |
EP (3) | EP1624884A4 (zh) |
JP (2) | JP4578470B2 (zh) |
KR (2) | KR20070108953A (zh) |
CN (2) | CN101791409A (zh) |
AU (1) | AU2004232314B2 (zh) |
CA (1) | CA2523197C (zh) |
IL (1) | IL171204A (zh) |
MX (1) | MXPA05011233A (zh) |
NO (1) | NO20054494L (zh) |
NZ (2) | NZ576739A (zh) |
RU (1) | RU2361876C2 (zh) |
SG (1) | SG173223A1 (zh) |
WO (1) | WO2004093807A2 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103804472A (zh) * | 2014-01-23 | 2014-05-21 | 浙江大学 | 一种紫杉烷类药物前体 |
WO2015196944A1 (zh) * | 2014-06-26 | 2015-12-30 | 中国人民解放军军事医学科学院毒物药物研究所 | GnRH类似物-细胞毒分子缀合物、其制备方法及用途 |
WO2025112214A1 (zh) * | 2023-12-01 | 2025-06-05 | 深圳碳云智肽药物科技有限公司 | 一种多肽偶联喜树碱衍生物及其抗肿瘤应用 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05011233A (es) * | 2003-04-22 | 2005-12-14 | Conseils De Rech S Et D Aplica | Vectores peptidicos. |
CN101563360A (zh) * | 2006-10-20 | 2009-10-21 | 益普生制药两合公司 | 肽-细胞毒性缀合物 |
NZ577039A (en) * | 2006-10-20 | 2011-11-25 | Ipsen Pharma Sas | Peptide-cytotoxic conjugates comprising campthoecin and a somatostatin |
RU2377247C2 (ru) * | 2007-12-27 | 2009-12-27 | Федеральное государственное образовательное учреждение высшего профессионального образования Санкт-Петербургский государственный университет | Молекулярный конъюгат на основе синтетических аналогов люлиберина и его применение в качестве средства доставки днк в клетки гормон-чувствительных опухолей (варианты) |
SG11201610880RA (en) * | 2014-06-30 | 2017-01-27 | Tarveda Therapeutics Inc | Targeted conjugates and particles and formulations thereof |
CN108473538B (zh) | 2015-10-28 | 2022-01-28 | 塔弗达治疗有限公司 | Sstr靶向缀合物及其颗粒和制剂 |
WO2019115611A1 (en) * | 2017-12-12 | 2019-06-20 | Universität Leipzig | Peptidic bb2 receptor agonist – saccharide functionalised carbaborane conjugates |
CN109999202B (zh) * | 2019-01-18 | 2022-03-22 | 南阳师范学院 | 一种介导紫杉醇递送的多功能肽及其应用 |
JP2022530823A (ja) * | 2019-05-02 | 2022-07-01 | ザ・ユニバーシティ・オブ・シドニー | がん治療のためのペプチド誘導体とそのコンジュゲート |
SG11202111402PA (en) | 2019-05-14 | 2021-11-29 | Nuvation Bio Inc | Anti-cancer nuclear hormone receptor-targeting compounds |
EP4051309A4 (en) * | 2019-10-31 | 2023-11-08 | Worcester Polytechnic Institute | LHRH-PACLITAXEL CONJUGATES AND METHODS OF USE THEREOF |
WO2021097046A1 (en) | 2019-11-13 | 2021-05-20 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
MX2023011241A (es) | 2021-03-23 | 2023-10-03 | Nuvation Bio Inc | Compuestos dirigidos a receptores de hormonas nucleares contra el cancer. |
US12006314B2 (en) | 2021-05-03 | 2024-06-11 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
Family Cites Families (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4291022A (en) | 1975-03-11 | 1981-09-22 | Sandoz Ltd. | Organic compounds |
US4133782A (en) | 1976-06-07 | 1979-01-09 | The Salk Institute For Biological Studies | Somatostatin analogs with dissociated biological activities |
US4190575A (en) | 1977-12-27 | 1980-02-26 | American Home Products Corporation | Polypeptides related to somatostatin |
DE2860734D1 (en) | 1977-06-08 | 1981-09-03 | Merck & Co Inc | Somatostatin analogs, process for their preparation and pharmaceutical compositions containing them |
US4211693A (en) | 1977-09-20 | 1980-07-08 | The Salk Institute For Biological Studies | Peptides with para-substituted phenylalanine |
LU78191A1 (de) | 1977-09-28 | 1979-05-25 | Ciba Geigy Ag | Verfahren zur herstellung von neuen cyclopeptiden |
CA1107273A (en) | 1978-05-19 | 1981-08-18 | Chester A. Meyers | Somatostatin analogs having a substituted tryptophyl residue in position eight |
JPS5819669B2 (ja) | 1978-10-28 | 1983-04-19 | 白井松新薬株式会社 | 新規生理活性ペプチド化合物及びその製造法 |
US4215039A (en) | 1979-02-15 | 1980-07-29 | American Home Products Corporation | Somatostatin analogues |
US4190648A (en) | 1979-03-13 | 1980-02-26 | Merck & Co., Inc. | Peptides having somatostatin activity |
US4316890A (en) | 1979-03-16 | 1982-02-23 | Ciba-Geigy Corporation | Peptides and processes for the manufacture thereof |
US4209426A (en) | 1979-05-29 | 1980-06-24 | American Home Products Corporation | Polypeptides related to somatostatin |
US4431635A (en) | 1979-06-13 | 1984-02-14 | Coy David Howard | LH-RH Antagonists |
US4317815A (en) | 1979-06-13 | 1982-03-02 | Coy David Howard | LH-RH Antagonists |
US4328214A (en) | 1979-07-04 | 1982-05-04 | Ciba-Geigy Corporation | Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture |
US4235886A (en) | 1979-10-31 | 1980-11-25 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
US4310518A (en) | 1979-10-31 | 1982-01-12 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
ATE2512T1 (de) | 1979-11-27 | 1983-03-15 | Sandoz Ag | Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung. |
US4369179A (en) | 1979-12-14 | 1983-01-18 | Ciba-Geigy Corporation | Acylpeptides |
EP0031303A3 (de) | 1979-12-21 | 1981-11-04 | Ciba-Geigy Ag | Cyclooctapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung |
US4282143A (en) | 1980-06-13 | 1981-08-04 | American Home Products Corporation | Octapeptides lowering growth hormone |
DK81082A (da) | 1981-03-06 | 1982-09-07 | Sandoz Ag | Fremgangsmaade til fremstilling af polypeptider |
US4360516A (en) | 1981-04-13 | 1982-11-23 | Merck & Co., Inc. | Modified D-retro cyclic hexapeptide somatostatin analogs |
AU9102582A (en) | 1981-12-10 | 1983-06-16 | David Howard Coy | Lh-rh antagonists |
DE3264693D1 (en) | 1981-12-24 | 1985-08-14 | Ciba Geigy Ag | Cyclic octapeptides and pharmaceutical compositions thereof, and processes for their production and use |
FR2522655B1 (fr) | 1982-03-05 | 1987-03-06 | Sanofi Sa | Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant |
US4581169A (en) | 1982-12-21 | 1986-04-08 | Syntex (U.S.A.) Inc. | Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists |
US4486415A (en) | 1983-08-15 | 1984-12-04 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
DE3467173D1 (en) | 1983-08-16 | 1987-12-10 | Akzo Nv | Lh- rh antagonists |
US4485101A (en) | 1983-10-11 | 1984-11-27 | Administrators Of The Tulane Educational Fund | Peptides |
US4522813A (en) | 1983-10-27 | 1985-06-11 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
US4684620A (en) | 1984-09-04 | 1987-08-04 | Gibson-Stephens Neuropharmaceuticals, Inc. | Cyclic polypeptides having mu-receptor specificity |
US5075224A (en) | 1984-10-19 | 1991-12-24 | Genentech, Inc. | Prepro-LHRH C-terminal peptide DNA |
HUT42101A (en) | 1985-01-07 | 1987-06-29 | Sandoz Ag | Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds |
US4650787A (en) | 1985-04-25 | 1987-03-17 | Schally Andrew Victor | Biologically active octapeptides |
US4725577A (en) | 1985-04-25 | 1988-02-16 | Administrators Of The Tulane Educational Fund | Biologically active lysine containing octapeptides |
US4656247A (en) | 1985-04-26 | 1987-04-07 | Board Of Regents, The University Of Texas System | Effective hormonal peptides: D-3-QA1 6-LHRH |
US4642332A (en) | 1985-04-26 | 1987-02-10 | The Board Of Regents, The University Of Texas System | Effective hormonal peptides: D-3-Pal6 -LHRH |
US4585755A (en) | 1985-04-29 | 1986-04-29 | Merck & Co., Inc. | Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents |
US5525338A (en) | 1992-08-21 | 1996-06-11 | Immunomedics, Inc. | Detection and therapy of lesions with biotin/avidin conjugates |
US4721775A (en) | 1985-08-26 | 1988-01-26 | Board Of Regents, The University Of Texas System | Effective peptides related to the luteinizing hormone releasing hormone from L-amino acids |
US4904642A (en) | 1985-09-12 | 1990-02-27 | The Administrators Of The Tulane Educational Fund | Therapeutic somatostatin analogs |
US4853371A (en) | 1986-06-17 | 1989-08-01 | The Administrators Of The Tulane Educational Fund | Therapeutic somatostatin analogs |
US4871717A (en) | 1987-01-07 | 1989-10-03 | Administrators Of The Tulane Educational Fund | Peptides |
US5877277A (en) | 1987-09-24 | 1999-03-02 | Biomeasure, Inc. | Octapeptide bombesin analogs |
US5723578A (en) | 1987-09-24 | 1998-03-03 | The Administrators Of Tulane Educational Fund | Peptide analogs of bombesin |
JP2795449B2 (ja) | 1987-09-24 | 1998-09-10 | ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド | 治療用ペプチド |
US5084555A (en) | 1989-08-21 | 1992-01-28 | The Administrators Of The Tulane Educational Fund | An octapeptide bombesin analog |
US4943579A (en) | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
WO1989007451A1 (en) | 1988-02-10 | 1989-08-24 | Abbott Laboratories | Reduced size lhrh analogs |
US5140009A (en) | 1988-02-10 | 1992-08-18 | Tap Pharmaceuticals, Inc. | Octapeptide LHRH antagonists |
GB8808768D0 (en) | 1988-04-14 | 1988-05-18 | Erba Carlo Spa | Peptide ligands for bombesin receptors |
GR1000608B (el) | 1988-07-21 | 1992-08-31 | Erba Carlo Spa | Μεθοδος για την παρασκευη ανταγωνιστων bombesin. |
ZA895838B (en) | 1988-08-18 | 1991-03-27 | Syntex Inc | Pharmaceutical compounds |
JP2919889B2 (ja) | 1988-10-14 | 1999-07-19 | アドミニストレイターズ オブ ザ テューレイン エデュケイショナル ファンド | 治療用ペプチド |
CA2012115C (en) | 1989-03-15 | 2001-07-03 | Biomeasure, Inc. | Iodinated somatostatins |
US5484592A (en) | 1989-03-23 | 1996-01-16 | Stitching Centraal Diergeneeskundig Instituut | Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs |
NL8900726A (nl) | 1989-03-23 | 1990-10-16 | Stichting Centr Diergeneeskund | Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens. |
WO1990012811A1 (en) | 1989-04-26 | 1990-11-01 | The Administrators Of The Tulane Educational Fund | Linear somatostatin analogs |
CA2016584C (en) | 1989-05-17 | 1999-06-29 | Robert S. Greenfield | Anthracycline conjugates having a novel linker and methods for their production |
GB8913844D0 (en) | 1989-06-15 | 1989-08-02 | Erba Carlo Spa | Irreversible bombesin antagonists |
US5217955A (en) | 1989-09-15 | 1993-06-08 | Biomeasure, Inc. | Treatment of cancer with peptide analog of bombesin, grp, litorin or neuromedin |
CA2045494A1 (en) | 1989-11-06 | 1991-05-07 | Luigia Gozzini | Reduced irreversible bombesin antagonists |
NZ236114A (en) | 1989-11-22 | 1993-04-28 | Merrell Dow Pharma | Peptide antagonists of bombesin and of gastrin releasing peptide, and pharmaceutical compositions |
CA2046594A1 (en) | 1989-12-08 | 1991-06-09 | David H. Coy | Octapeptide analogs of somatostatin having threonine at the sixth position |
ES2076393T3 (es) | 1990-04-06 | 1995-11-01 | Univ Tulane | Analogos de lhrh. |
DK0450480T3 (da) | 1990-04-06 | 1995-08-14 | Univ Tulane | Somatostatinaloger |
WO1991017181A1 (en) | 1990-05-09 | 1991-11-14 | The Administrators Of The Tulane Educational Fund | Cyclized and linear therapeutic peptides |
IT1240643B (it) | 1990-05-11 | 1993-12-17 | Mediolanum Farmaceutici Spa | Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano |
ZA915740B (en) | 1990-07-26 | 1992-05-27 | Merrell Dow Pharma | Peptides |
US5369094A (en) | 1990-11-29 | 1994-11-29 | The Administrators Of The Tulane Educational Fund | Polypeptide bombesin antagonists |
HU207104B (en) | 1991-01-25 | 1993-03-01 | Biosignal Kutato Fejlesztoe Kf | Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds |
CA2081660C (en) | 1991-03-01 | 2001-05-01 | Raymond Dufour | Method for improving the organoleptic qualities of the meat from uncastrated male domestic animals and vaccine set for use in this method |
US5436137A (en) | 1992-07-27 | 1995-07-25 | Oregon Regional Primate Research Center | DNA sequence which encodes a peptide capable of promoting acrosome reaction |
CA2136079A1 (en) | 1992-12-18 | 1994-07-07 | Fortuna Haviv | Lhrh antagonists having modified aminoacyl residues at positions 5 and 6 |
US5482698A (en) | 1993-04-22 | 1996-01-09 | Immunomedics, Inc. | Detection and therapy of lesions with biotin/avidin polymer conjugates |
DE69431114T2 (de) | 1993-04-27 | 2003-03-13 | United Biomedical, Inc. | Immunogene lhrh peptidkonstrukion und synthetische, universale immunstimulatoren als impfstoffe |
EP0626170A3 (en) | 1993-05-10 | 1996-03-27 | Sandoz Ltd | Stabilization of pharmacologically active compounds in delayed release agents. |
US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
US5620955A (en) | 1993-06-18 | 1997-04-15 | Peptide Technologies Corporation | Bombesin receptor antagonists and uses thereof |
US5410018A (en) | 1994-02-25 | 1995-04-25 | Oregon Regional Primate Research Center | Bombesin-related peptides |
US5843901A (en) | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
USRE39048E1 (en) | 1995-06-07 | 2006-03-28 | Pepscan Systems B.V. | Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine |
EP0831880A4 (en) | 1995-06-07 | 2004-12-01 | Imclone Systems Inc | ANTIBODIES AND FRAGMENTS OF ANTIBODIES INHIBITING TUMOR GROWTH |
ES2163631T3 (es) | 1995-06-07 | 2002-02-01 | Dlo Inst Voor Dierhouderij En | Un peptido mejorado, composicion inmunogenica y vacuna o preparacion medica, un procedimiento para inmunizar a los animales contra la hormona lhrh, analogos del peptido lhrh repetidos en tandem y su uso como vacuna. |
GB9513121D0 (en) * | 1995-06-28 | 1995-08-30 | Merck Sharp & Dohme | Therapeutic agents |
MY147327A (en) | 1995-06-29 | 2012-11-30 | Novartis Ag | Somatostatin peptides |
KR0144618B1 (ko) * | 1995-09-29 | 1998-07-15 | 김완섭 | 음식물 쓰레기 처리방법 |
US5843903A (en) | 1995-11-27 | 1998-12-01 | The Administrators Of The Tulane Educational Fund | Targeted cytotoxic anthracycline analogs |
US7078413B2 (en) | 1996-04-19 | 2006-07-18 | Wisconsin Alumni Research Foundation | Compositions and methods of use for a bombesin peptide |
AU717020B2 (en) | 1996-05-03 | 2000-03-16 | Immunomedics Inc. | Targeted combination immunotherapy of cancer |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US6156725A (en) | 1996-08-16 | 2000-12-05 | National Institute Of Immunology | Drug for the treatment of cancer |
AU4005697A (en) | 1996-08-23 | 1998-03-06 | Patel, Cell & Receptor Technologies Inc. | Agonist-dependent internalization of human somatostatin receptors types 1-5 |
EP0835662B1 (en) | 1996-10-08 | 2001-11-14 | National Institute of Immunology | A drug for the treatment of cancer |
US5948750A (en) | 1996-10-30 | 1999-09-07 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
US6063796A (en) | 1997-04-04 | 2000-05-16 | Merck & Co., Inc. | Somatostatin agonists |
US6025372A (en) | 1997-04-04 | 2000-02-15 | Merck & Co., Inc. | Somatostatin agonists |
US6057338A (en) | 1997-04-04 | 2000-05-02 | Merck & Co., Inc. | Somatostatin agonists |
US7060247B2 (en) | 1997-04-22 | 2006-06-13 | The Curators Of The University Of Missouri | Gastrin receptor-avid peptide conjugates |
RU2184122C2 (ru) * | 1997-05-14 | 2002-06-27 | Байер Акциенгезельшафт | Гликоконъюгаты 20(s)-камптотецина |
US20020115596A1 (en) | 1997-10-27 | 2002-08-22 | Merk & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
WO1999022735A1 (en) | 1997-10-30 | 1999-05-14 | Merck & Co., Inc. | Somatostatin agonists |
ATE274357T1 (de) | 1998-06-05 | 2004-09-15 | Univ Texas | Texaphyrin-konjugate und ihre anwendiung |
US6025468A (en) | 1998-06-20 | 2000-02-15 | United Biomedical, Inc. | Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
GB9814527D0 (en) * | 1998-07-03 | 1998-09-02 | Cyclacel Ltd | Delivery system |
GB2343182A (en) | 1998-10-27 | 2000-05-03 | Ferring Bv | Use of GnRH-II and analogues thereof for the treatment of osteoporosis |
EP1154782A4 (en) | 1999-02-24 | 2002-09-25 | Uab Research Foundation | TAXAN DERIVATIVES FOR TARGETED CANCER THERAPY |
US6716452B1 (en) | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
KR100821437B1 (ko) | 1999-10-12 | 2008-04-10 | 쎌세러퓨틱스,인코포레이티드 | 폴리글루타메이트-치료제 접합체의 제조 방법 |
AU4267700A (en) * | 2000-01-13 | 2001-07-19 | Academia Sinica | Application of somatostatin analogs to specific delivery of anti-tumor drugs into tumor cells |
US8263739B2 (en) * | 2000-06-02 | 2012-09-11 | Bracco Suisse Sa | Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
EP2286843A3 (en) * | 2000-06-02 | 2011-08-03 | Bracco Suisse SA | Compounds for targeting endothelial cells |
JP2002047298A (ja) * | 2000-07-10 | 2002-02-12 | Academia Sinica | 新規抗がん剤伝達系 |
EP1198478B1 (en) | 2000-07-31 | 2005-03-23 | Dabur Research Foundation | Somatostatin analogs and their use for the treatment of cancer |
US6316414B1 (en) | 2000-07-31 | 2001-11-13 | Dabur Research Foundation | Somatostatin analogs for the treatment of cancer |
DE60141992D1 (zh) * | 2000-09-05 | 2010-06-10 | Biosight Ltd | |
US7420030B2 (en) * | 2000-09-08 | 2008-09-02 | The Board Of Regents Of The University Of Texas System | Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
CA2421271A1 (en) * | 2000-09-08 | 2002-03-14 | Board Of Regents, The University Of Texas System | Human and mouse targeting peptides identified by phage display |
WO2002087497A2 (en) | 2001-04-26 | 2002-11-07 | Board Of Regents, The University Of Texas System | Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
AU2002314861A1 (en) | 2001-05-30 | 2002-12-09 | Targesome, Inc. | Targeted multivalent macromolecules |
KR20030033007A (ko) | 2001-05-31 | 2003-04-26 | 코울터 파머수티컬, 인코포레이티드 | 세포독소, 약물전구체, 링커 및 이에 유용한 안정화제 |
CN1514843A (zh) * | 2001-06-08 | 2004-07-21 | �о���Ӧ�ÿ�ѧЭ��ɷ�����˾ | 生长激素释放抑制因子-多巴胺嵌合类似物 |
US7893223B2 (en) * | 2001-07-17 | 2011-02-22 | Bracco Imaging S.P.A. | Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
WO2003020906A2 (en) | 2001-08-31 | 2003-03-13 | Abmaxis, Inc. | Multivalent protein conjugate with multiple ligand-binding domains of receptors |
PL369336A1 (en) | 2001-09-21 | 2005-04-18 | The Administrators Of The Tulane Educational Fund | Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
WO2003026577A2 (en) * | 2001-09-24 | 2003-04-03 | Seattle Genetics, Inc. | P-amidobenzylethers in drug delivery agents |
US20030083241A1 (en) | 2001-11-01 | 2003-05-01 | Young Charles W. | Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation |
US7189856B2 (en) | 2001-12-28 | 2007-03-13 | Gideon Shapiro | Non-peptide somatostatin receptor ligands |
WO2003072754A2 (en) | 2002-02-27 | 2003-09-04 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
JP2006514915A (ja) * | 2002-03-01 | 2006-05-18 | ダイアックス、コープ | Kdrおよびvegf/kdr結合ペプチドならびに診断および治療におけるその使用 |
PL373567A1 (en) | 2002-03-01 | 2005-09-05 | The Administrators Of The Tulane Educational Fund | Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
US7211240B2 (en) * | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
WO2004093804A2 (en) | 2003-04-18 | 2004-11-04 | Five Prime Therapeutics, Inc. | Human polypeptides encoded by polynucleotides and methods of their use |
MXPA05011233A (es) * | 2003-04-22 | 2005-12-14 | Conseils De Rech S Et D Aplica | Vectores peptidicos. |
TWI262192B (en) * | 2003-07-01 | 2006-09-21 | Univ Nat Taiwan | Labeling peptide for nasopharyngeal carcinoma (NPC) cells |
NZ577039A (en) * | 2006-10-20 | 2011-11-25 | Ipsen Pharma Sas | Peptide-cytotoxic conjugates comprising campthoecin and a somatostatin |
-
2004
- 2004-04-21 MX MXPA05011233A patent/MXPA05011233A/es active IP Right Grant
- 2004-04-21 CA CA2523197A patent/CA2523197C/en not_active Expired - Fee Related
- 2004-04-21 CN CN201010003734A patent/CN101791409A/zh active Pending
- 2004-04-21 KR KR1020077024090A patent/KR20070108953A/ko not_active Ceased
- 2004-04-21 US US10/554,240 patent/US8709998B2/en not_active Expired - Fee Related
- 2004-04-21 EP EP04760052A patent/EP1624884A4/en not_active Withdrawn
- 2004-04-21 NZ NZ576739A patent/NZ576739A/xx not_active IP Right Cessation
- 2004-04-21 NZ NZ564694A patent/NZ564694A/xx not_active IP Right Cessation
- 2004-04-21 EP EP13167747.8A patent/EP2662087A1/en not_active Withdrawn
- 2004-04-21 RU RU2005136221/04A patent/RU2361876C2/ru not_active IP Right Cessation
- 2004-04-21 EP EP09177270A patent/EP2161037A3/en not_active Withdrawn
- 2004-04-21 KR KR1020057020113A patent/KR100817232B1/ko not_active Expired - Fee Related
- 2004-04-21 AU AU2004232314A patent/AU2004232314B2/en not_active Ceased
- 2004-04-21 SG SG2007184005A patent/SG173223A1/en unknown
- 2004-04-21 CN CNA2004800105826A patent/CN1777439A/zh active Pending
- 2004-04-21 WO PCT/US2004/012200 patent/WO2004093807A2/en active Application Filing
- 2004-04-21 JP JP2006513164A patent/JP4578470B2/ja not_active Expired - Fee Related
-
2005
- 2005-09-28 NO NO20054494A patent/NO20054494L/no not_active Application Discontinuation
- 2005-09-29 IL IL171204A patent/IL171204A/en not_active IP Right Cessation
-
2010
- 2010-06-11 JP JP2010133732A patent/JP2010265271A/ja active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103804472A (zh) * | 2014-01-23 | 2014-05-21 | 浙江大学 | 一种紫杉烷类药物前体 |
CN103804472B (zh) * | 2014-01-23 | 2016-06-08 | 浙江大学 | 一种紫杉烷类药物前体 |
WO2015196944A1 (zh) * | 2014-06-26 | 2015-12-30 | 中国人民解放军军事医学科学院毒物药物研究所 | GnRH类似物-细胞毒分子缀合物、其制备方法及用途 |
WO2025112214A1 (zh) * | 2023-12-01 | 2025-06-05 | 深圳碳云智肽药物科技有限公司 | 一种多肽偶联喜树碱衍生物及其抗肿瘤应用 |
Also Published As
Publication number | Publication date |
---|---|
NZ564694A (en) | 2009-11-27 |
KR100817232B1 (ko) | 2008-03-27 |
RU2361876C2 (ru) | 2009-07-20 |
JP2010265271A (ja) | 2010-11-25 |
WO2004093807A2 (en) | 2004-11-04 |
NZ576739A (en) | 2011-01-28 |
EP2662087A1 (en) | 2013-11-13 |
RU2005136221A (ru) | 2006-05-27 |
EP1624884A2 (en) | 2006-02-15 |
CN1777439A (zh) | 2006-05-24 |
NO20054494L (no) | 2006-01-09 |
EP2161037A2 (en) | 2010-03-10 |
US20070093645A1 (en) | 2007-04-26 |
IL171204A (en) | 2013-01-31 |
KR20060003047A (ko) | 2006-01-09 |
JP4578470B2 (ja) | 2010-11-10 |
WO2004093807A3 (en) | 2005-08-04 |
AU2004232314B2 (en) | 2007-11-22 |
AU2004232314A1 (en) | 2004-11-04 |
SG173223A1 (en) | 2011-08-29 |
EP1624884A4 (en) | 2009-08-05 |
MXPA05011233A (es) | 2005-12-14 |
KR20070108953A (ko) | 2007-11-13 |
CA2523197C (en) | 2016-05-24 |
US8709998B2 (en) | 2014-04-29 |
JP2006524256A (ja) | 2006-10-26 |
NO20054494D0 (no) | 2005-09-28 |
EP2161037A3 (en) | 2010-05-26 |
CA2523197A1 (en) | 2004-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010265271A (ja) | ソマトスタチンベクター | |
US7732412B2 (en) | Methods of treatment using novel LHRH antagonists having improved solubility properties | |
JPH10500397A (ja) | Gnrh拮抗剤 | |
JPH07507330A (ja) | ポリペプチドのボンベシン拮抗物質 | |
CA2376506C (en) | Neuromedin b and somatostatin receptor agonists | |
JP4988851B2 (ja) | ペプチド−細胞傷害性コンジュゲート | |
RU2248982C9 (ru) | Антагонисты lhrh, их получение, фармацевтическая композиция и ее получение, способ лечения опухолей и бесплодия у млекопитающих | |
JP3662926B2 (ja) | Lhrhのn末端改変類似体 | |
US20080132453A1 (en) | Neuromedin B and somatostatin receptor agonists | |
JP2010150253A (ja) | 肝癌を治療するための薬剤 | |
HK1142011A (zh) | 喜樹鹼(camptothecin)-體抑素(somatostatin)結合物 | |
AU2007221964B2 (en) | Peptide vectors | |
HK1135409A (zh) | 肽-细胞毒性缀合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20100804 |